Catheter funnel extension

Information

  • Patent Grant
  • 11883043
  • Patent Number
    11,883,043
  • Date Filed
    Tuesday, March 31, 2020
    4 years ago
  • Date Issued
    Tuesday, January 30, 2024
    3 months ago
Abstract
The present disclosure includes a system for retrieving a blood clot in a blood vessel using a clot retrieval device having an expansile funnel that can engage with the blood clot. The present disclosure also includes a clot retrieval device having an expandable framework that can engage with the blood clot. The expansile funnel and expandable framework can expand from a collapsed delivery state to an expanded deployed state, increasing the cross-sectional area of the clot retrieval device engaging the blood clot. The increased cross-sectional area of the clot retrieval device can increase the suction force, providing effective removal of the clot from the patient.
Description
FIELD OF INVENTION

The present invention generally relates to systems and methods for removing acute blockages from blood vessels during intravascular medical treatments.


BACKGROUND

Clot retrieval catheters and devices are used in mechanical thrombectomy for endovascular intervention, often in cases where patients are suffering from conditions such as acute ischemic stroke (AIS), myocardial infarction (MI), and pulmonary embolism (PE). The immediate hours after these life-threatening events are critical, as a clot that occurs within a blood vessel must be removed as soon as possible to prevent long term disability, brain damage, or death. Accessing the neurovascular bed can be challenging with conventional technology, as the target vessels are small in diameter, remote relative to the site of insertion, and highly tortuous. Traditional devices are often either too large in profile, lack the deliverability and flexibility needed to navigate tortuous vessels, or are not entirely effective at removing a clot when delivered to the target site. Further, tissue plasminogen activator (“tPA”) has been the traditional, FDA-approved treatment for removing blood clots in the brain; however, when the blood clot is in a major blood vessel, tPA can become less effective. This drawback has stimulated the need for a device that can effectively and quickly remove blood clots in major blood vessels.


The clot itself can additionally complicate procedures by embodying a number of complex morphologies and consistencies, ranging from simple tube-shaped structures which assume the shape of the vessel to long, strand-like arrangements that can span multiple vessels at one time. The age of a clot can also affect its compliance, with older clots tending to be less compressible than fresh clots. Experience has also demonstrated that depending on the nature of the interaction with a clot retrieval device, the mechanical properties of a clot can be affected in a significant way. Additionally, several mechanisms can play a role in strongly adhering the clot to the vessel wall. Breaking these bonds without damaging fragile neurovascular vessels can be a significant challenge.


The delivery of effective devices to the small and highly-branched cerebral artery system remains challenging, and conventional clot retrieval devices can suffer from a number of drawbacks. The retrieval device must also be sufficiently flexible to navigate the vasculature and endure high strains, while also having the axial stiffness to offer smooth advancement along the route. Once at the target site, typical objects to be retrieved from the body are substantially larger in size than the device, making it more difficult to retrieve objects into the tip. For example, firm, fibrin-rich clots can often be difficult to extract as they can become lodged in the tip of traditional fixed-mouth catheters and devices. Additionally, this lodging can cause softer portions to shear away from the firmer regions of the clot.


Small diameters and fixed tip sizes are also less efficient at directing the aspiration necessary to remove blood and thrombus material during the procedure. The suction must be strong enough such that any fragmentation that can occur as a result of aspiration or the use of a mechanical thrombectomy device can be held stationary so that fragments cannot migrate and occlude distal vessels. However, when aspirating with a fixed-mouth catheter or device, a significant portion of the aspiration flow ends up coming from vessel fluid proximal to the tip of the catheter or device, where there is no clot. This can significantly reduce aspiration efficiency, lowering the success rate of clot removal.


Applicants therefore recognize a need for improved methods, devices, and systems that can incorporate an expansile funnel that deploys outside a catheter, allowing for effective and quick retrieval of blood clots due to the greater thrombus removal force resulting from the increased area engaging the thrombus. Additionally, there is a need for improved methods, devices, and systems that incorporate a stent retriever having an expandable framework that functions as a funnel catheter tip extension to provide effective and quick retrieval of blood clots.


SUMMARY

Generally, system for retrieving a blood clot in a blood vessel using a clot retrieval device having an expansile funnel that can engage with the blood clot is provided. The present disclosure also includes a clot retrieval device having an expandable framework that can engage with the blood clot. The expansile funnel and expandable framework can expand from a collapsed delivery state to an expanded deployed state, increasing the cross-sectional area of the clot retrieval device engaging the blood clot. The increased cross-sectional area of the clot retrieval device can increase the aspiration suction force, providing effective removal of the clot from the patient.


An example system for retrieving an obstruction in a blood vessel can include an outer catheter facilitating the introduction of microcatheters, guidewires, or any of a number of commercially available products to a target site within the vasculature. The outer catheter can be one or both of a guide catheter and an intermediate catheter. Within the outer catheter can be a clot retrieval device. The clot retrieval device can include an elongate flexible delivery wire having a distal end; an expansile tube having a lumen and being affixed to the distal end of the elongated flexible wire; and an expansile funnel affixed to the expansile tube. The expansile funnel can be expandable from a collapsed delivery state, in which the expansile funnel can have a circumference approximately the size of the lumen of the outer catheter, to an expanded deployed state, in which the expansile funnel can have a circumference greater than the circumference of the lumen of the outer catheter. The expansile funnel can include a fluid-impermeable flexible tube; an open distal mouth at the distal end of the flexible tube; and a first and second ring of struts affixed to and structurally supported by the flexible tube. The fluid-impermeable flexible tube can include a lumen in fluid communication with the lumen of the expansile funnel. The second ring of struts can be positioned proximal to the first ring of struts. An aspiration source can be attached to the system to apply suction through a fluidic passage of the outer catheter and the clot retrieval device.


When the expansile funnel is in the expanded deployed state, approximately half of the clot retrieval device can be positioned within the lumen of the outer catheter, while approximately half of the clot retrieval device can be positioned within a blood vessel.


When the expansile funnel is in the expanded deployed state and the expansile tube is positioned within the lumen of the outer catheter, the outer walls of the expansile tube can form a seal against the lumen of the outer catheter.


When the expansile funnel is in the expanded deployed state, the expansile funnel can expand to circumferentially appose a lumen of the blood vessel.


When the expansile funnel is in the collapsed delivery state, a portion of the expansile funnel and the expansile tube can have common circumferential dimensions.


When the expansile funnel is in the collapsed delivery state and is positioned within the lumen of the outer catheter, the lumen of the flexible tube, the lumen of the expansile tube, and the lumen of the outer catheter can be aligned coaxially about a longitudinal axis.


The fluid-impermeable flexible tube can provide the sole structural support for the expansile funnel between the first and second ring of struts. The fluid-impermeable flexible tube can be stitched and/or adhered to the first ring of struts and the second ring of struts. The fluid-impermeable flexible tube can include flexible polymer material.


Another example system can include an outer catheter facilitating the introduction of microcatheters, guidewires, or any of a number of commercially available products to a target site within the vasculature. The outer catheter can be one or both of a guide catheter and an intermediate catheter. Within a lumen of the outer catheter can be a stent retriever. The stent retriever can include an elongate flexible delivery wire; an expandable framework; and a fluid-impermeable membrane. The expandable framework can engage and capture the obstruction within a blood vessel by expanding from a collapsed delivery configuration to an expanded deployed configuration. A proximal end of the expandable framework can be attached to a distal end of the delivery wire. The expandable framework can include a tubular portion that can have an elongated tubular shape when expanded. The expandable framework can taper proximally from the tubular portion to the distal end of the delivery wire. The fluid-impermeable membrane can be affixed to the expandable framework near the proximal end of the framework such that the fluid-impermeable membrane has a funnel shape when the expandable framework is in the expanded configuration.


The tubular portion of the expandable framework can have multiple cell openings sized to pass through the obstruction when the expandable framework expands from the collapsed delivery configuration.


The system can include the expandable framework including a closed distal end portion extending distally away from the tubular portion of the framework and radially inward towards a central axis.


The tubular portion can be expandable to have approximately the same circumference as the circumference of the blood vessel when the expandable framework is in the expanded deployed configuration, allowing for complete engagement with the obstruction.


The system can include a microcatheter sized to traverse the lumen of the outer catheter. The expandable framework can be sized to traverse a lumen of the microcatheter when in the collapsed delivery state.


When deployed a blood vessel as part of a treatment, the fluid-impermeable membrane can include a first outer circumference approximately equal to an inner circumference of the lumen of the outer catheter and a second outer circumference approximately equal to the inner circumference of the blood vessel. When the expandable framework is in the expanded configuration, a portion of the proximal portion of the expanded framework can be positioned within the lumen of the outer catheter. This configuration can provide an outer force on the lumen of the outer catheter such that a fluid-impermeable seal is created between the fluid-impermeable membrane and the lumen of the outer catheter. This configuration can further provide a force between the fluid impermeable membrane and the walls of the blood vessel such that a fluid-impermeable seal is created between the fluid-impermeable membrane and the walls of the blood vessel.


An example method for retrieving an obstruction from a blood vessel can include one or more of the following steps presented in no particular order. The example method can include additional steps as would be appreciated and understood by a person of ordinary skill in the art. The example method can be performed by an example system as disclosed herein, a variation thereof, or an alternative thereto as would be appreciated and understood by a person of ordinary skill in the art.


The method can include accessing an arterial blood vessel of a patient using an outer catheter; positioning a distal end of the outer catheter proximate to the obstruction; advancing a microcatheter and an expandable framework having a fluid-impermeable membrane, in a collapsed delivery state, through the lumen of the outer catheter; crossing the obstruction with the microcatheter and the expandable framework in the collapsed configuration; retracting the microcatheter into the lumen of the outer catheter while the expandable framework maintains contact with the obstruction; expanding a portion of the expandable framework through the obstruction; expanding a distal portion and proximal portion of the membrane to circumferentially appose the lumen of the outer catheter; and aspirating through a fluidic passage.


The method can include advancing the outer catheter to a distance approximately three millimeters away from the obstruction.


The method can include retracting a portion of the expandable framework into the lumen of the outer catheter while aspirating resulting in removing the expandable framework with the obstruction from the patient.


The method can include injecting contrast media within the lumen of the outer catheter to assess the degree of obstruction remaining in the blood vessel.





BRIEF DESCRIPTION OF THE DRAWINGS

The above and further aspects of this invention are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation. It is expected that those of skill in the art can conceive of and combining elements from multiple figures to better suit the needs of the user.



FIG. 1A is an illustration of a system for retrieving an obstruction using an expansile funnel, according to aspects of the present invention.



FIG. 1B is an illustration of a cross-sectional view of the interior of the expansile tube in FIG. 1A, according to aspects of the present invention.



FIG. 2 is an illustration of an expansile funnel including a first and second ring of struts, according to aspects of the present invention.



FIG. 3 shows a view of the system for retrieving an obstruction using an expansile funnel including a fluid-impermeable flexible tube, according to aspects of the present invention.



FIG. 4 is an illustration of a system for retrieving an obstruction using a stent retriever according to aspects of the present invention.



FIG. 5 shows a view of the system including a fluid-impermeable membrane and expandable framework on the stent retriever, according to aspects of the present invention.



FIG. 6 is an illustration of a stent retriever with a fluid-impermeable membrane, according to aspects of the present invention.



FIGS. 7A-7D are a series of views of the deployment of a stent retriever to remove an obstruction from a blood vessel according to aspects of the present invention.



FIGS. 8A-8H are a series of views of the method of removing an obstruction from a blood vessel using a first catheter, outer catheter, microcatheter, and stent retriever according to aspects of the present invention.



FIGS. 9A-9B illustrate the increased obstruction removal force provided by the disclosed technology compared to the obstruction removal force provided by commercially available products, according to aspects of the present invention.



FIG. 10 graphically depicts the obstruction removal force provided by the disclosed technology compared to the obstruction removal forced provided by commercially available products, according to aspects of the present invention.



FIG. 11 is a flow diagram outlining steps for removing an obstruction from a blood vessel according to aspects of the present invention.





DETAILED DESCRIPTION

Specific examples of the present invention are now described in detail with reference to the Figures, where identical reference numbers indicate elements which are functionally similar or identical.


A key success factor in intravascular treatment such as aneurysm treatments relates to the obstruction removal force defined as the product of the vacuum pressure times the catheter cross sectional area. In some treatments, mechanical clot removal devices referred to herein generically as “stent retrievers” are also used in combination with aspiration. In order to increase the obstruction removal force, either the vacuum pressure or the catheter cross-sectional area can be increased. The disclosed technology relates to a clot retrieval device including an expansile funnel that can increase the cross-sectional area of the device that can be in contact with the obstruction. Alternatively, the disclosed technology relates to a stent retriever including an expandable framework having a membrane thereon that can provide a sealed opening to the catheter lumen, the sealed opening providing a cross sectional area in contact with the obstruction that is greater than the catheter cross sectional area. Because the cross-sectional area is increased, the obstruction removal force can be increased, resulting in improved removal of an obstruction from a patient compared to suction through the catheter alone.


Accessing the various vessels within the vascular, whether they are coronary, pulmonary, or cerebral, involves well-known procedural steps and the use of a number of conventional, commercially-available accessory products. These products, such as angiographic materials, rotating hemostasis valves, and guidewires are widely used in laboratory and medical procedures. When these products are employed in conjunction with the system and methods of this invention in the description below, their function and exact constitution are not described in detail.



FIG. 1A illustrates a system 10 for retrieving an obstruction (T). FIG. 1B illustrates a cross section of the system 10 as indicated in FIG. 1A. Referring collectively to FIGS. 1A and 1B, the system 10 as illustrated includes a clot retrieval device 100 and an outer catheter 200. The clot retrieval device 100 is slidably translatable within the lumen 202 of the outer catheter 200 and expandable such that a distal funnel 106 portion of the device 100 expands to walls of the blood vessel (BV) and a proximal portion 104 of the device expands to the walls of the lumen 202 of the outer catheter 202 when the distal funnel 106 portion is slid distally to exit the outer catheter 200. The system 10 can be configured to aspirate through the catheter 200 and expanded device 100 to dislodge and/or extract an obstruction (T) including an occlusive clot or thrombus, debris, and/or other foreign mass within a blood vessel (BV) of a patient.



FIG. 2 illustrates an end perspective view of a system 10a including a clot retriever device 100a and an outer catheter 200. The device 100a illustrated in FIG. 2 can be configured to function according to the principles of the device 100 illustrated in FIGS. 1A and 1B. The system 10a illustrated in FIG. 2 can be configured to be positioned within a blood vessel (BV) and retrieve an obstruction (T) similar to the system 10 as illustrated in FIG. 1A. The distal funnel portion 106 of the device 100a as illustrated in FIG. 2 includes a fluid-impermeable flexible tube 110a affixed to a strut framework 116a. The strut framework 116a includes a first, distal ring of struts 112 and a second ring of struts 114 positioned in the proximal direction (PD) in relation to the first ring of struts 112. The first and second ring of struts 112, 114 can be disposed approximate to the open distal mouth 108 of the expansile funnel 106. In some examples, the device 100a can include one or more additional rings of struts positioned in the proximal direction (PD) in relation to the first and second ring of struts 112, 114. In some examples, the strut framework 116a can extend into the lumen 105 of the expansile tube 104. In some examples, the first and second rings of struts 112, 114 are separated such that the flexible tube 110a structurally supports each ring of struts 112, 114. The distal end of the fluid-impermeable flexible tube 110a can define an open distal mouth 108 of the device 100a. In some examples, the cover 110a can be a fluid-impermeable flexible tube fixed to the strut framework 116a. The fluid-impermeable flexible tube 110a can be stitched to the strut framework 116a, as illustrated in FIG. 2.



FIG. 3 illustrates a side view of a system 10b including a clot retriever device 100b and an outer catheter 200. The device 100b illustrated in FIG. 3 can be configured to function according to the principles of the device 100 illustrated in FIGS. 1A and 1B. The system 10b illustrated in FIG. 3 can be configured to be positioned within a blood vessel (BV) and retrieve an obstruction (T) similar to the system 10 as illustrated in FIG. 1A. The expansile tube 104 and distal funnel 106 of the device 100b illustrated in FIG. 3 can include a strut framework 116b and a fluid impermeable tube, coating, or membrane 110b. In contrast to the framework 116a illustrated in FIG. 2, the framework 116b illustrated in FIG. 3 can be contiguous. The framework 116b illustrated in FIG. 3 can be shaped, made of suitable materials, and otherwise constructed to structurally support the fluid-impermeable cover 110b. In some examples, the cover 110b can include a fluid-impermeable flexible tube, and the tube 110b can be adhered to the strut framework 116b. The fluid-impermeable flexible 110 can be adhered to the strut framework 116a by applying heat.


Referring collectively to FIGS. 1A, 1B, 2, and 3 the outer catheter 200 can be sized, constructed, and otherwise configured to navigate the blood vessel (BV) to a treatment site and facilitate introduction of the clot retrieval device 100, 100a, 100b across the obstruction (T). In one example, the outer catheter 200 can be an aspiration catheter. The aspiration catheter can be a rapid-exchange (RX) type. The outer catheter 200 can include a lumen 202 traversing the length of the outer catheter 200. The lumen 202 can be sized to receive a clot retrieval device 100, 100a, 100b and provide sufficient space for the clot retrieval device 100 to move through the lumen 202 along a longitudinal axis as the system 10 approaches and engages with the obstruction (T). The system 10, 10a, 10b can include an aspiration source (AS) that can be configured to apply suction through a fluidic passage within the lumen 202 of the outer catheter 204. The aspiration source (AS) can provide sufficient suction for engaging the clot retrieval device 100, 100a, 100b with an obstruction (T) to effectively remove the obstruction (T) from a blood vessel (BV) of a patient. In one example, the aspiration source (AS) can be first applied to the lumen 202 of the outer catheter 200 and then directed to the expansile funnel 106 of the clot retrieval device 100, 100a, 100b.


The clot retrieval device 100, 100a, 100b can include a flexible delivery member 102 (also referred to herein generically as “delivery wire”), an expansile tube 104, and an expansile funnel 106. The expansile tube 104 can be affixed at a distal end of the delivery wire 102, and the expansile funnel 106 can extend distally from the expansile tube 104. The clot retrieval device 100 including the delivery wire 102, expansile tube 104, and expansile funnel 106 can be sized to fit within the lumen 202 of the outer catheter 200. The device 100, 100a, 100b can, but need not include a defined transition between the expansile tube 104 and the expansile funnel 106.


During delivery of the system 10, 10a, 10b through vasculature, the device 100, 100a, 100b can be retained completely within the lumen 202 of the outer catheter 200 as the catheter 200 is translated through vasculature. Once the distal end of the catheter 200 is positioned near the obstruction (T), the delivery wire 102 can be pushed distally to move the expansile funnel 106 distally out of the lumen 202 of the catheter 200. The expansile funnel 106 can be expandable to circumferentially appose the walls of the blood vessel on the proximal side of the obstruction (T) while the expansile tube 104 remains positioned within the lumen 202 of the catheter 200. The distal mouth 108 of the expansile funnel 106 can have a circumference 210 when expanded in the blood vessel (BV) that is approximately equal to the circumference 212 of the interior of the blood vessel (BV). The expansile funnel 106 can therefore be expandable to an expanded deployed state having an outer circumference 210 that is greater than the circumference 208 of the lumen 202 of the outer catheter 200. The expansile funnel 106 can provide fluidic passage to a lumen 105 of the expansile tube 104. The lumen 105 of the expansile tube 104 can be in fluidic communication with the lumen 202 of the catheter 200 such that when the aspiration source (AS) is applied, the aspiration force can sufficiently reach the obstruction (T). The expansile tube 104 can expand to have an outer circumference that is approximately equal to the circumference 208 of the lumen 202 of the outer catheter 200.


The expansile tube 104 can be disposed proximate to the distal end of the delivery wire 102. The expansile tube 104 can be affixed to a plurality of connecting struts 120 disposed on the distal end of the delivery wire 102. The expansile tube 104 can expand and retract to accommodate delivery catheters having different diameters.


Referring collectively to FIGS. 1A, 1B, 2, and 3, the delivery wire 102 can be coated with hydrophilic and/or hydrophobic lubricious polymer including polyvinylpyrrolidone, polytetrafluoroethylene, or silicone to reduce friction between the components of the system 10, 10a, 10b and the components of the system 10, 10a, 10b and the blood vessel (BV). The delivery wire 102 can have sufficient flexibility for a physician to maneuver the clot retrieval device 100, 100a, 100b through the blood vessel (BV), but also sufficient stiffness to effectively guide the clot retrieval device 100, 100a, 100b to the target site. In one example, the delivery wire 102 can be solid steel. In another example, the delivery wire 102 can be a nitinol core wire. In one example, the distal end 103 of the delivery wire 102 can include a plurality of connecting struts 120. The connecting struts 120 can comprise the same material as the delivery wire 102. The connecting struts 120 can connect the distal end 103 of the delivery wire 102 to the expansile tube 104, as illustrated in FIG. 1B.


The expansile funnel 106 can be affixed to the distal end of the expansile tube 104. The expansile funnel 106 can be expanded from a collapsed delivery state to an expanded deployed state. In the collapsed delivery state, the expansile funnel 106 is sized to traverse the lumen 202 of the outer catheter 200. In this configuration, the expansile funnel 106 can be folded or collapsed upon itself in order to adequately fit within the lumen 202 of the outer catheter 200. The expansile funnel 106 can fold or collapse radially inward towards a longitudinal axis. In the collapsed delivery state, at least a portion of the expansile funnel 106 and the expansile tube 104 can have a common circumference. In the collapsed delivery state, the lumen 111 of a fluid-impermeable flexible tube 110, the lumen 105 of the expansile tube 104, and the lumen 202 of the outer catheter 200 can be aligned coaxially about a longitudinal axis (LA). In this configuration, the clot retrieval device 100 can be transported through the body using catheters of varying diameters until the clot retrieval device 100 is proximate to the obstruction (T) in the blood vessel (BV).


The expansile funnel 106 can assume the expanded configuration by self-extending radially outward from the longitudinal axis upon exiting the distal end of the outer catheter 200. In one example in which the expansile funnel 106 can be folded or compressed, when the expansile funnel 106 is in the collapsed delivery state, the expansile funnel 106 can provide a spring-like force that facilitates self-expansion of the expansile funnel 106 when the expansile funnel 106 exits the outer catheter 200. In the expanded deployed state, the expansile funnel 106 can expand such that the expansile funnel 106 has an outer circumference 210 greater than the circumference 208 of the lumen 202 of the outer catheter 200. In one example, the expansile funnel 106, when in the expanded deployed state, can have a circumference 210 approximately equal to the circumference 212 of the interior of the blood vessel (BV). The expansile funnel 106 can thus seal with the blood vessel (BV) or create enough of a restriction such that when aspiration is applied, blood and the clot distal of the distal mouth 108 of the expansile funnel 106 will be drawn into the clot retrieval device 100, 100a, 100b rather than blood proximal of the expansile funnel 106. In the expanded deployed state, at least a portion of the clot retrieval device 100 can be positioned within the lumen 202 of the outer catheter 200. In one example, in the expanded deployed state, approximately half of the clot retrieval device 100, 100a, 100b can be positioned within the lumen 202 of the outer catheter 200. The clot retrieval device 100, 100a, 100b can be positioned coaxially along a longitudinal axis (LA) within the lumen 202 of the outer catheter 202. In the expanded deployed state, at least a portion of the clot retrieval device 100, 100a, 100b can be positioned within the lumen of the blood vessel (BV). In one example, in the expanded deployed state, approximately half of the clot retrieval device 100, 100a, 100b can be positioned within the lumen of the blood vessel (BV).


The expansile funnel 106 can include a distal mouth 108. In the expanded deployed state, the distal mouth 108 can be open and configured to engage the obstruction (T). The open distal mouth 108 can have a circumference approximately equal to the circumference 212 of the blood vessel (BV). The distal mouth 108 can have a circumference approximately equal to or larger than the circumference of the obstruction (T). Because the open distal mouth 108 has a circumference approximately equal to or larger than the circumference of the obstruction, the distal mouth 108 of the expansile funnel 106 can engage and receive the obstruction (T). When the aspiration source is connected and suction begins, the obstruction expansile funnel 106 can further receive the obstruction (T), such that the obstruction (T) can be pulled into the expansile funnel 106, and particularly into the lumen 111 of the fluid-impermeable flexible tube 110. The expansile funnel 106 can be progressively compressed during retrieval of the obstruction (T) to a small diameter so that it can be fully received within the expansile tube 104 of the clot retrieval device 100, 100a, 100b. The obstruction (T) can then be safely and effectively removed from the patient. If the obstruction (T) does become lodged in the distal mouth 108, the open mouth 108 will protect the obstruction (T) and prevent it from dislodging as the aspiration suction is maintained and the clot retrieval device 100, 100a, 100b is retracted into the sheath or outer catheter 200.


The large distal mouth 108 of the clot retrieval device 100, 100a, 100b of systems 10, 10a, 10b illustrated herein can offer improved performance over conventional fixed-mouth designs. Traditional fixed-mouth catheters can be hindered by having firm, fibrin-rich clots lodge in the tip of a catheter, or by having softer portions of the clot shear away. When aspirating through a fixed-mouth catheter, a significant portion of the suction can be directed to fluid proximal of the tip, reducing the suction directed to the clot and the success rate of clot removal. As the diameter of an expandable distal mouth 108 can be close to that of the vessel, clot shearing at the mouth of the catheter can be mitigated and the volume of fluid and clot distal of the mouth secured. However, the expansile funnel 106 of the disclosed technology can increase the amount of suction force by increasing the cross-sectional area of engagement between the expansile funnel and the obstruction, resulting in more effective removal of an obstruction (T).



FIG. 1B is a cross-sectional view of the interior of the expansile tube 104 when the clot retrieval device 100 is in an expanded deployed state. As illustrated in FIG. 1B, the delivery wire 102 can include connecting struts 120. The connecting struts 120 can be fixed to the walls of the expansile tube 104. A fluid-impermeable flexible tube, membrane, coating, or other cover 110 can cover at least a portion of the outer walls of expansile tube 104. A seal 118 can form against the inner walls of the outer catheter 200 when the outer walls of the expansile tube 104 exert force on the inner walls of the outer catheter 200. The seal 118 can direct the aspiration source to the obstruction (T) and ensure the clot retrieval device 100 can capture the obstruction (T). The cover 110 can be affixed or integrated with the expansile tube 104 and otherwise configured to expand to create a seal between the outer surface of the membrane 110 and the inner walls of the lumen 202 of the outer catheter 200. The lumen 105 of the expansile tube 104 can be in fluid communication with the lumen 202 of the catheter 200 such that when the aspiration source (AS) is applied, the aspiration force can sufficiently reach the obstruction (T) with minimal to no flow between the membrane or cover 110 and the inner walls of the lumen 202.


The clot capture devices 100a, 100b illustrated in FIG. 2 and FIG. 3 can similarly include a cover 110 over the proximal portion 104 of the device 100a, 100b. The outer flexible tube 110a illustrated in FIG. 2 can extend to cover the proximal portion of the device 100a to form the cover 110 illustrated in FIG. 1B. The fluid-impermeable flexible tube 110a of the device 100a illustrated in FIG. 2 can include a lumen 111. The lumen 105 of the proximal expansile tube 104 can be in fluid communication with the lumen 111 of the fluid-impermeable flexible tube 110a, such that when the aspiration source (AS) is applied, the aspiration force can sufficiently reach the obstruction (T). Alternatively, the proximal expansile tube 104 of the device 100a illustrated in FIG. 2 can include a separate cover, coating, membrane, or seal to guide aspiration through the funnel 106 and catheter lumen 202.


Likewise, the cover 110b (fluid-impermeable flexible tube, membrane, coating, or other cover) of the device 100b illustrated in FIG. 3 can extend over the funnel 104 and tube 104 portions of the device 100b, or the funnel 106 and tube 104 can be non-uniformly covered. The cover 110b can extend within the expansile tube 104. The cover 110b can cover at least a portion of the inner walls of the expansile tube 104.


Referring collectively to FIGS. 1A, 1B, 2, and 3 the device 100, 100a, 100b can include a distal end 122. The distal end 122 can correspond to a distal end of the cover 110, 110a, 110b of the funnel 106 of the device 100, 100a, 100b. In examples where the cover 110, 110a, 110b extends to the proximal expansile tube 104 of the device 100, 100a, 100b, the distal end 122 of the cover 110, 110a, 110b can have a greater circumference 210 than a proximal end of the cover 110, 110a, 110b when the clot retrieval device 100, 100a, 100b is in the expanded deployed state. The distal end 122 can have a circumference at least the size of the circumference of the obstruction (T), allowing expansile funnel 106 including the cover 110, 110a, 110b to receive the obstruction (T) when an aspiration source (AS) is applied. The cover 110, 110a, 110b can include flexible, polymer material. For example, the cover 110, 110a, 110b can be formed from a ductile elastomer, which has the advantages of being soft and flexible with resistance to tearing and perforation due to a high failure strain. In one example, the cover 110, 110a, 110b can comprise urethane or other similar material. The cover 110, 110a, 110b can provide the clot retrieval device 100, 100a, 100b with advantageous properties, such as high tensile strength, resistance to degradation, biocompatibility, and flexibility. The fluid-impermeable flexible tube 110 can also be configured to minimize friction between the cover 110, 110a, 110b and the blood vessel (BV), reducing strain on the blood vessel (BV). The flexible nature of the cover 110, 110a, 110b can allow the cover 110, 110a, 110b to stretch as the expansile funnel 106 expands from the collapsed delivery state to the expanded deployed state. As the cover 110, 110a, 110b stretches, the cover 110, 110a, 110b can follow the contours of an underlying strut framework 116. In some examples, such as illustrated in FIG. 2, the cover 110a can include a flexible tube that can structurally support the strut framework 116a to maintain position of first and second rings 112, 114 of struts relative to each other. The cover 110a can further include a construction with sufficient structural integrity so that the strut framework 116a can be stitched to the cover 110a. The funnel 106 portion of the device 100a can therefore further include sutures or other stitching to affix the cover 110a to the framework 116a as illustrated in FIG. 2.


The strut framework 116a, 116b can have a variety of configurations that are not illustrated in FIG. 1A, 1B, 2, or 3. The configuration of the strut framework 116a, 116b can be such that the profile of the expansile funnel 106 in the expanded deployed state can hinge radially outward to have a portion appose the circumference 212 of the blood vessel (BV). The strut framework 116a, 116b can include a plurality of closed cells, loops, or undulations. In one example, the strut framework 116a, 116b can include a plurality of distal crowns. In one example, the strut framework 116a, 116b can have petal shaped cells with rounded edges. The petal shaped cells can open in the expanded deployed state to assume a maximum radial size.


In one example, the cover 110, 110a, 110b can include a fluid-impermeable flexible tube that provides the sole structural support of the expansile funnel 106. As illustrated in FIG. 2, the fluid-impermeable flexible tube 110a can provide the sole structural support of the expansile funnel 106 in the area between the first ring of struts 112 and the second ring of struts 114. As illustrated in FIG. 3, the strut framework 116 can provide support for the expansile funnel 106.


The ideal diameter of the clot retrieval device 100, 100a, 100b depends on the location of the target obstruction and the diameter of the outer catheter 200 through which the clot retrieval device 100, 100a, 100b can be delivered. For retrieval of clots in the cerebral vascular bed, where vessel diameters commonly around 3 mm to 6 mm, an applicable system might have an outer catheter 200 with an inner diameter of about 0.070 inches (1.8 mm) and a clot retrieval device 100 with an inner diameter of about 0.062 inches (1.6 mm). Upon deployment from the outer catheter 200, the maximum diameter of the expansile funnel 106 could be a minimum of 3 mm (but in some instances about 5-6 mm), allowing it to seal against the walls of the blood vessel (BV) and providing an opening at the distal mouth as large as the blood vessel (BV) itself.



FIGS. 4-6 include illustrations of an alternative system 10c for retrieving an obstruction (T) in a blood vessel (BV). The system 10c can include a catheter 200 and a funneled stent retriever 300 that includes an expandable framework 304 for engaging an obstruction (T), the framework 304 having a fluid-impermeable membrane, cover, or tube affixed to a proximal portion thereof. The obstruction (T) can include an occlusive clot within a blood vessel (BV) of a patient. The obstruction can include debris or other foreign material or mass within a blood vessel (BV). The outer catheter 200 can include a lumen 202 sized, shaped, and otherwise configured to slidably receive the funneled stent retriever 300. The catheter 200 can otherwise be sized and configured as illustrated and disclosed elsewhere herein. FIG. 4 illustrates the system 10c expanded through an obstruction (T) in a blood vessel (BV). FIG. 5 illustrates the system 10c expanded as illustrated in FIG. 4 with struts of the expandable framework 304 illustrated. FIG. 6 illustrates the funneled stent retriever 300 expanded without being restricted by the catheter 200 or the blood vessel (BV).


Referring collectively to FIGS. 4-6, the funneled stent retriever 300 can be disposed within the lumen 202 of the outer catheter 202 during delivery of the device. The funneled stent retriever 300 can move along a longitudinal axis as the system 10c approaches and engages with an obstruction (T).


The funneled stent retriever 300 can include an elongate flexible member 102, referred to herein generically as “a delivery wire”. The delivery wire 102 can facilitate positioning the stent retriever 300 proximate to the obstruction (T). The delivery wire 102 can be coated with hydrophilic and/or hydrophobic lubricious polymer including polyvinylpyrrolidone, polytetrafluoroethylene, or silicone to reduce friction between the components of the system 10c and the components of the system 10c and the blood vessel (BV). The delivery wire 102 can have sufficient flexibility for a physician to maneuver the stent retriever 300 through the blood vessel (BV), but also sufficient stiffness to effectively guide the stent retriever 300 to the target site. In one example, the delivery wire 102 can be solid steel. In another example, the delivery wire 102 can be a Nitinol core wire. In one example, a distal end 103 of the delivery wire 102 can include a plurality of connecting struts 120. The connecting struts 120 can include the same material as the delivery wire 102. The connecting struts 120 can connect the distal end 103 of the delivery wire 102 to the expansile tube 104, as illustrated in FIGS. 4-6. The delivery wire 102 and connecting struts can be configured as otherwise illustrated and described herein.


The stent retriever 300 can include an expandable framework 304 configured to engage and capture the obstruction (T). The framework 304 is illustrated having a structure similar to as disclosed in U.S. Pat. No. 9,445,829 which is hereby incorporated by reference as if set forth in its entirety herein. Alternatively, the expanded framework 304 can have a structure similar to other known frameworks of stent retriever devices or variations thereof as understood by a person of ordinary skill in the art according to the teachings of the present disclosure. As a non-exhaustive list of such frameworks of stent retriever devices, U.S. Pat. Nos. 10,292,723, 8,852,205, 9,301,769, 10,229,881, 10,420,570, 10,201,360, and 10,363,054 and U.S. Pat. Pub. Nos. 2017/0071614 are hereby incorporated by reference as if set forth in their entirety herein.


The expandable framework 304 can be made of material capable of self-expanding to an expanded configuration once released from the collapsed delivery state, such as a shape memory material. Additionally, or alternatively, the expandable framework 304 can be made of super elastic material. In one example, the superlattice alloy can be Nitinol or an alloy of similar properties. In one example, the super elastic alloy can include nickel and titanium. The expandable framework 304 can have a plurality of forms. The expandable framework 304 can be manufactured by laser cutting a Nitinol tube and then applying heat and electropolish to create a desired framework. The expandable framework 304 can include a radiopaque marker that can allow the expandable framework 304 to be visible using fluoroscopy.


When the expandable framework 304 is in an expanded deployed configuration, the expandable framework 304 can have a substantially tubular shape. In the expanded deployed configuration, the expandable framework 304 can include a tubular portion 310, a proximal portion 306 and a distal portion 312. The tubular portion 310 can extend distally from the proximal portion 306. The proximal portion 306 of the expandable framework 304 can be fixed to the distal end 103 of the delivery wire 102. In one example, the proximal portion 306 can be fixed to the distal end 103 of the delivery wire 102 by a collar joint 316, as illustrated in FIG. 6. The collar joint 316 can include features and functionality of one or more collar joints disclosed elsewhere, for example in U.S. patent application Ser. Nos. 16/150,024 and 16/667,454 each incorporated by reference as if set forth in their entirety herein.


In an alternate example, the proximal portion 306 can be welded to the distal end 103 of the delivery wire 102. When the expandable framework 304 is in an expanded deployed configuration, the proximal portion 306 of the expandable framework 304 can be tapered, such that the proximal portion 306 narrows from the tubular portion 310 to the point at which the expandable framework 304 can be fixed to the delivery wire 102. The tapering of the proximal portion 306 can create a funnel-like shape, as illustrated in FIGS. 4-6. The distal portion 312 can extend distally from the tubular portion 310. When the expandable framework 304 is in an expanded deployed configuration, the distal portion 312 can taper, such that the distal portion 312 narrows from the tubular portion to a distal junction 326. The distal portion 312 can be closed, having cell openings sized sufficiently small to inhibit clot material from traveling distally from the interior of the framework 304 through the distal portion 312. Alternatively, funnel stent retriever need not include a tapered or closed distal portion 312, for instance, the distal end of the framework 304 can be open.


The tapering of the distal portion 312 can create a conical or funnel-like shape, as illustrated in FIGS. 4-6. The distal portion 312 can include a distal coil 328, as illustrated in FIG. 6. The distal coil 328 and the distal portion 312 can attach at a distal junction 326. The distal junction 326 can be a collared joint.


The ideal diameter of the expandable framework can depend on the location of the target obstruction and the diameter of the outer catheter through which the expandable framework 304 is delivered. For retrieval of clots in the internal carotid artery, where vessel diameters can be between approximately 3 mm and 6 mm, an applicable system 10c can include an expandable framework 304 of between approximately 3 mm and 6 mm. In one example, the expandable framework 304 can be slightly greater than the diameter of the blood vessel (BV), forming a seal with the inner walls of the blood vessel. The ideal length of the expandable framework 304 can depend on the location of the target and characteristics of the obstruction (T). In one example, the length of the expandable framework 304 can be approximately 30 mm. In another example, the length of the expandable framework can be approximately 40 mm.


As illustrated in FIG. 6, in one example, the expandable framework 304 can include an inner body 318 and an outer body 320. The inner body 318 can be disposed within the outer body 320. The inner body 318 can have a substantially longitudinal, tubular shape and traverse the length of the tubular portion 310 of the expandable framework 304. The inner body 318 and the outer body 320 can be connected to distal end 103 of the delivery wire 102. The inner body 318 can include a distal portion 324 proximate to the distal portion 312 of the expandable framework 304. The distal portion 324 of the inner body 318 can have a particular wire configuration that can facilitate engagement with an obstruction (T) and prevent the fragments of the obstruction from escaping the expandable framework 304. The particular wire configuration can have a substantially vertically-oriented ellipse shape. The particular wire configuration can be affixed to the inner body 318, the outer body 320, or both.


The stent retriever 300 can include a fluid-impermeable membrane 308. The fluid-impermeable membrane 308 can be affixed to the proximal portion 306 of the expandable framework 304. The fluid-impermeable membrane 308 can also be affixed to the expandable framework 304 extending into the lumen 202 of the outer catheter 200. The fluid-impermeable membrane 308 can be made of porous material. The porous material can include pores sized to be smaller than the size of blood molecules, thereby preventing blood molecules from passing through the fluid-impermeable membrane 208. The flexible nature of the fluid-impermeable membrane 308 allows the fluid-impermeable membrane 308 to stretch as the expandable framework expands from the collapsed delivery state to the expanded deployed state. As the fluid-impermeable membrane 308 stretches, the membrane 308 can follow the contours of an underlying expandable framework 304. In one example, the fluid-impermeable membrane 308 can cover at least a portion of the proximal portion 306 of the expandable framework 304. In another example, the fluid-impermeable membrane 308 can cover the entire proximal portion 306 of the expandable framework. The fluid-impermeable membrane 308 can cover the proximal portion 306 of the expandable framework 304 extending into the lumen 202 of the outer catheter 200. When the fluid-impermeable membrane 308 covers at least a portion of the proximal portion 306 of the expandable framework 304 and the expandable framework 304 extending into the lumen 202 of the outer catheter 200, a funnel-like shape can be created. The fluid-impermeable membrane 308 can include a proximal opening sized to permit aspiration. In the expanded deployed configuration, the circumference of the proximal opening can be approximately equal to the circumference 208 of the lumen 202 of the outer catheter 200. When an aspiration force is applied, the proximal opening can permit aspiration through the funnel-like shape of the fluid-impermeable membrane, facilitating retrieval of the obstruction (T).


The expandable framework 304 can have a collapsed delivery configuration and an expanded deployed configuration. In the collapsed delivery configuration, system 10c can include a microcatheter 204. The microcatheter 204 can be sized to traverse the lumen 202 of the outer catheter 200. In the collapsed delivery configuration, the expandable framework 304 can collapse into itself such that the expandable framework 304 can be positioned within the lumen 205 of the microcatheter 204.


In the collapsed delivery state, the first outer circumference 212 and the second outer circumference 214 of the fluid-impermeable membrane 308 can be approximately equal. The first circumference 212 and the second circumference 214 can be approximately equal to the circumference 220 of the lumen 205 of the microcatheter 204. In the collapsed delivery state, the first circumference 212, the second outer circumference 214, the circumference 330 of the tubular portion 310 of the expandable framework 304, and the circumference 220 of the lumen 205 of the microcatheter 204 can be approximately equal.


In the expanded deployed state, the tubular portion 310 of the expandable framework 304 can expand such that the circumference 330 of the tubular portion 310 is substantially equal to the circumference 212 of the blood vessel (BV). In one example, the funneled stent retriever 300 can be configured to treat an obstruction (T) having a circumference that is substantially equal to the circumference of the blood vessel (BV). In another example, the funneled stent retriever 300 can be configured to treat an obstruction (T) having a circumference smaller than the circumference of the blood vessel (BV). Because the tubular portion 310 can expand such that its circumference can be substantially equal to the circumference of the blood vessel (BV), the expandable framework 304 can fully engage with the obstruction (T).


In the expanded deployed state, the fluid-impermeable membrane can include a first outer circumference 212 and a second outer circumference 214. The first outer circumference 212 can be approximately equal to the circumference 208 of the lumen 202 of the outer catheter 200, as illustrated in FIG. 5. The second outer circumference 214 can be approximately equal to an inner circumference 212 of a blood vessel (BV), as illustrated in FIG. 5. The difference in circumferences 212, 214 of the fluid-impermeable membrane 308, can allow the membrane 308 to have a substantially funnel shape in the expanded deployed configuration.


In the expanded deployed state, the portion of the proximal portion 306 of the expandable framework 304 extending into the lumen 202 of the outer catheter 200 can create an outward force on the inner walls of the outer catheter 200. The outward force can be sufficient to create a fluid-impermeable seal 332 between the fluid-impermeable membrane 308 covering the proximal portion of the expandable framework 304 extending into the lumen 202 of the outer catheter 200 and lumen 202 of the outer catheter 200, as illustrated in FIG. 5. The fluid-impermeable seal 332 can facilitate aspiration and thus, removal of the obstruction (T) from the blood vessel (BV), as the aspiration suction is directed to the obstruction (T).



FIGS. 7A-7D and 8A-8H illustrate methods of removing an obstruction (T) from a blood vessel (BV) using a system 10c including a stent retriever 300 with an expandable framework 304. FIGS. 7A-7D are drawings at the target site illustrating delivery of a stent retriever 300 to the target site and capture of the obstruction (T). FIGS. 8A-8H are drawings of vasculature near the target site illustrating delivery of the stent retriever 300 to the target site, capture of the obstruction (T), and removal of the stent retriever 300 from the patient's body. The drawings of FIGS. 8A-8H are based on photographs of a prototype system 10c retrieving a clot (T) in a silicone model of vasculature near the Circle of Willis.



FIGS. 9A and 9B illustrate significant improvements clot retrieval devices 100a, 100b, 300 can provide compared to other commercially available products. FIG. 9A illustrates data comparing dimensions and operation of a prototype clot retrieval device constructed similar to devices 100a, 100b illustrated in FIGS. 2 and 3. FIG. 9B illustrates data comparing dimensions and operation of a prototype clot retrieval device constructed similar to device 300 illustrated in FIGS. 4 through 8H.


Optimal retrieval of an obstruction (T) from a blood vessel (BV) can depend on obstruction removal force. Obstruction removal force can be defined as the product of vacuum pressure applied multiplied by the cross-section area of the clot retrieval device engaging the obstruction (T). When the thrombus removal force is high, the obstruction (T) can be firmly held to the clot retrieval device, resulting in effective removal of the obstruction (T). Increasing the vacuum pressure applied can be one method of increasing the obstruction removal force. However, vacuum pressure can only be increased to a realistic limit (e.g. based on design constraints as understood by a person of ordinary skill in the art). Further, increasing the internal diameter, and thus, cross-section area of a catheter can present challenges, as larger catheters can be more difficult to track and can increase the potential for vessel damage.


Accordingly, clot retrieval devices 100a, 100b, and 300 as disclosed herein are configured to significantly increase the cross-section area engaging the obstruction (T), and thus increase the obstruction removal force as compared to commercially available products. By way of example, as illustrated in FIGS. 9A and 9B, the expansile funnel 106 of clot retrieval device 100a, 100b and the funneled stent retriever 300 can each expand to a distal internal diameter of approximately equal to an internal diameter of a blood vessel in which the device 100a, 100b, 300 is deployed. Assuming a blood vessel having an internal diameter of 0.16 inches or approximately 4 millimeters, regardless of the specific embodiment of the device 100a, 100b, 300, the device can expand to have a distal internal diameter of approximately 4 millimeters and can have a cross-section area of approximately 0.030 square inches or 2.0×(10−5) square meters. When approximately 29 Hg (98000 Pascals) of vacuum pressure is applied, the resulting obstruction removal force at the expansile funnel can be approximately 1.2 Newtons (approximately 127 gram-force), regardless of the specific embodiment of the device 100a, 100b, 300. In contrast, when commercially available catheters, as identified in FIG. 9A, having a distal internal diameter of approximately 0.070 inches or 1.8 millimeters and a cross-section area of approximately 0.003 square inches or 2.0×(10−6) square meters are subjected to a vacuum pressure of approximately 98000 Pascals, the resulting obstruction removal force at the catheter tip can be from approximately 0.21 to approximately 0.26 Newtons (approximately 21 to 27 gram-force). In this instance, clot retrieval device 100a, 100b, 300 can provide a cross-section area at the tip of the clot retrieval device 100a, 100b, 300 of approximately 1,000% larger than other commercially available products resulting in an obstruction removal force approximately 500% higher than other commercially available products.



FIG. 10 graphically illustrates the significantly increased obstruction removal force clot retrieval device 100a, 100b, 300 can provide as compared to commercially available products. In the illustrated example, EMBOVAC has the highest thrombus holding force of approximately 26 gram-force and the highest tip cross sectional area of 2.6×(10−6) square meters of the tested commercially available devices. Clot retrieval devices 100a, 100b, 300 of the present disclosure have a tip cross sectional area and holding force of more than 4 times (nearly 5 times) that of the EMBOVAC. Further, the cross sectional area (and therefore holding force) of the clot retrieval devices 100a, 100b, 300 are limited in this illustration by the 4 millimeter vessel diameter, therefore the tip cross sectional area and holding force can be greater in a blood vessel having a larger diameter.



FIG. 11 is a flow diagram illustrating the method 400 of delivering a system including a funneled stent retriever 300 to a target site, capturing an obstruction, and removing the stent retriever 300 from the patient's body. The method can include one or more of the following steps presented in no particular order. The example method 400 can include additional steps as appreciated and understood by a person of ordinary skill in the art. The example method can be performed by an example device as disclosed herein, a variation thereof, or an alternative thereto as appreciated and understood by a person of ordinary skill in the art.


An artery of the brain can be accessed using a long guide wire 216. Once a distal tip of the guide wire 216 reaches the target site, the guide wire 216 can act as a guide that larger catheters can follow for delivery to the target site. The guide wire 216 can be constructed from solid steel, nitinol core, or other suitable material. In one example, vasculature can be accessed using a guide catheter such as a balloon catheter.


In step 402, an arterial blood vessel of a patient can be accessed using a first catheter 206 comprising a lumen 207, an aspiration catheter 200 comprising a lumen 202, and a microcatheter 204 comprising a lumen 205. As illustrated in FIGS. 7A and 8A, the first catheter 206 can have the largest diameter of the catheter delivery system. The first catheter 206 can be the initial catheter that enters the blood vessel (BV) of the patient. The aspiration catheter 200 can be disposed within the lumen 207 of the first catheter 206. The aspiration catheter 200 can be the second catheter that enters the blood vessel (BV) of the patient. The microcatheter 204 can be disposed within the lumen 202 of the aspiration catheter 200. The microcatheter can have the smallest diameter of the delivery catheter system and can be sized to receive the stent retriever 300 within its lumen 205. The catheters 206, 200, 204 can be advanced over a guide wire 216 positioned across the obstruction (T) as illustrated in FIGS. 7A and 8A.


In step 404, the aspiration catheter 200 can be advanced through the lumen 207 of the first catheter 206 and towards a proximal end of the obstruction (T) using conventionally known techniques, as illustrated in FIGS. 7A and 8B. In one example, the outer catheter 200 is advanced through the lumen 207 of the first catheter 206 until the outer catheter 200 is approximately three millimeters away from the obstruction (T).


In step 406, a microcatheter 204 having an expandable framework 304 collapsed therein can be advanced through the lumen 202 of the outer catheter 200 and towards the proximal end of the obstruction (T) as illustrated in FIGS. 7A and 8A. The expandable framework 304 can include a fluid-impermeable membrane 308 affixed thereto that is collapsed within the lumen 207 of the microcatheter 204 as the microcatheter 204 is advanced. The guide wire 216 and the outer catheter 200 can be manipulated as necessary while advancing the microcatheter 204 towards the obstruction (T).


In step 408, the microcatheter 204 having the expandable framework 304 collapsed within the lumen 207 of the microcatheter 204 can cross the obstruction (T), as illustrated in FIGS. 7B and 8C. The guide wire 216 can subsequently be removed from the system 10c. The expandable framework 304 can be advanced through the microcatheter 204 until the distal end of the expandable framework 304 breaches the distal tip of the microcatheter 204 as illustrated in FIG. 8D.


In step 410, the microcatheter 204 can be retracted into the lumen 202 of the outer catheter 200, while a majority of the expandable framework 304 remains across the obstruction (T), as illustrated in FIGS. 7C, 7D, 8E, and 8F.


In step 412, at least a portion of the expandable framework 304 can be expanded to engage the obstruction (T), as illustrated in FIGS. 7C, 7D, 8E, and 8F. As the microcatheter 204 is retracted into the lumen 202 of the outer catheter 200 in step 410, the expandable framework 304 can self-expand. Additionally, or alternatively, the expandable framework 304 can exhibit a spring force while the expandable framework 304 is within the lumen 205 of the microcatheter 204 that acts to facilitate a spring-like expansion when the expandable framework 304 is moved out of the lumen 205 of the microcatheter 204.


In step 414, a distal portion of the fluid-impermeable membrane 308 can be expanded, as illustrated in FIGS. 8E and 8F. In one example, the distal portion of the fluid-impermeable membrane 308 can be expanded to circumferentially appose the blood vessel (BV). In this configuration, the fluid-impermeable membrane 308 is proximate to the inner walls of the blood vessel (BV).


In step 416, a proximal portion of fluid-impermeable membrane 308 can be expanded, as illustrated in FIGS. 7D, 8E, and 8F. In one example, the proximal portion of the fluid-impermeable membrane 308 can be expanded to circumferentially appose the lumen 202 of the outer catheter 200. In this configuration, the fluid-impermeable membrane 308 can form a seal 332 against the inner walls of the outer catheter 200.


In step 418, an aspiration source can be connected to the system 10c. The aspiration source can generate a vacuum pressure that can aspirate through a fluidic passage defined by the fluid-impermeable membrane 308 and the lumen 202 of the aspiration catheter 200. The suction can be sufficient to engage the stent retriever 300 and the obstruction (T) during removal of the obstruction.


In step 420, at least a portion of the expandable framework 304 can be retracted into the lumen 202 of the outer catheter 200, as illustrated in FIG. 8G. The expandable framework 304 can be retracted into the lumen 202 of the outer catheter 200 until a physician can feel a significant tactile force. The significant tactile force can signify the obstruction (T) is successfully positioned within the distal end of the outer catheter 200. At this time, the aspiration source can be substantially restricted or eliminated.


In step 422, the stent retriever 300 can be removed with the captured obstruction (T) from the patient as illustrated in FIG. 8H.


In one example, the contrast media can be injected within the lumen 202 of the outer catheter 200 to access the degree of obstruction remaining in the blood vessel (BV). The contrast media can include an iodine-based contrast material


The invention is not limited to the examples described, which can be varied in construction and detail. The terms “distal” and “proximal” are used throughout the preceding description and are meant to refer to a positions and directions relative to a treating physician. As such, “distal” or distally” refer to a position distant to or a direction away from the physician. Similarly, “proximal” or “proximally” refer to a position near to or a direction towards the physician.


In describing example embodiments, terminology is resorted to for the sake of clarity. It is intended that each term contemplates its broadest meaning as understood by those skilled in the art and includes all technical equivalents that operate in a similar manner to accomplish a similar purpose. It is also to be understood that the mention of one or more steps of a method does not preclude the presence of additional method steps or intervening method steps between those steps expressly identified. Steps of a method can be performed in a different order than those described herein without departing from the scope of the disclosed technology. Similarly, it is also to be understood that the mention of one or more components in a device or system does not preclude the presence of additional components or intervening components between those components expressly identified.


As discussed herein, a “patient” or “subject” can be a human or any animal. It should be appreciated that an animal can be a variety of any applicable type, including, but not limited to, mammal, veterinarian animal, livestock animal or pet-type animal, etc. As an example, the animal can be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g., rat, dog, pig, monkey, or the like).


As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values ±20% of the recited value, e.g. “about 90%” may refer to the range of values from 71% to 99%.


By “comprising” or “containing” or “including” is meant that at least the named compound, element, particle, or method step is present in the composition or article or method, but does not exclude the presence of other compounds, materials, particles, method steps, even if the other such compounds, material, particles, method steps have the same function as what is named.


It must also be noted that, as used in the specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Ranges can be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, other exemplary embodiments include from the one particular value and/or to the other particular value.


The descriptions contained herein are examples of embodiments of the invention and are not intended in any way to limit the scope of the invention. While particular examples of the present invention are described, various modifications to devices and methods can be made without departing from the scope and spirit of the invention. For example, while the examples described herein refer to particular components, the invention includes other examples utilizing various combinations of components to achieve a described functionality, utilizing alternative materials to achieve a described functionality, combining components from the various examples, combining components from the various example with known components, etc. The invention contemplates substitutions of component parts illustrated herein with other well-known and commercially-available products. Modifications recognized by one having ordinary skill in the art to which this invention relates are intended to be within the scope of the claims which follow.

Claims
  • 1. A system for retrieving an obstruction in a blood vessel, the system comprising: an outer catheter comprising a lumen therethrough; anda clot retrieval device disposed within the outer catheter and translatable through the lumen of the outer catheter, the clot retrieval device comprising: an elongate flexible member comprising a distal end;an expandable framework, configured to engage the obstruction, expandable from a collapsed delivery configuration to an expanded configuration, the expandable framework comprising a proximal portion affixed to the distal end of the elongate flexible member and a tubular portion extending distally from the proximal portion, the tubular portion comprising an elongated tubular shape when the expandable framework is in the expanded configuration, and the proximal portion tapering proximally from the tubular portion to the distal end of the flexible member when the expandable framework is in the expanded configuration; anda fluid-impermeable membrane affixed to the proximal portion of the expandable framework when the expandable framework is in the expanded configuration, the fluid-impermeable membrane further affixed to the tubular portion and extending into the lumen of the outer catheter when the expandable framework is in the expanded configuration, the fluid-impermeable membrane terminating distal of a proximal end of the expandable framework, and the fluid-impermeable membrane comprising a funnel shape around the proximal portion of the expandable framework when the expandable framework is in the expanded configuration,wherein a majority of the tubular portion of the expandable framework comprises cell openings sized to pass through the obstruction when the expandable framework expands from the collapsed delivery configuration to the expanded configuration.
  • 2. The system of claim 1, wherein the expandable framework further comprises a closed distal end portion extending distally from the tubular portion and radially inward to a central axis of the tubular portion.
  • 3. The system of claim 1, further comprising: a microcatheter sized to traverse the lumen of the outer catheter,wherein the expandable framework is sized to traverse a lumen of the microcatheter when the expandable framework is in the collapsed delivery configuration.
  • 4. The system of claim 1, wherein the tubular portion is expandable to circumferentially appose a lumen of the blood vessel when the expandable framework is in the expanded configuration.
  • 5. The system of claim 1, wherein, when the expandable framework is in the expanded configuration, the fluid-impermeable membrane comprises a first outer circumference approximately equal to an inner circumference of the lumen of the outer catheter, and a second outer circumference approximately equal to an inner circumference of the blood vessel.
  • 6. The system of claim 1, wherein when the expandable framework is in the expanded configuration, at least a portion of the proximal portion of the expandable framework is positioned within the lumen of the outer catheter, providing an outward force to the lumen of the outer catheter, andwherein the force is effective to create a fluid-impermeable seal between the fluid-impermeable membrane and the lumen of the outer catheter.
  • 7. A system for retrieving an obstruction in a blood vessel, the system comprising: an outer catheter comprising a lumen therethrough; anda clot retrieval device disposed within the outer catheter and translatable through the lumen of the outer catheter, the clot retrieval device comprising: an elongate flexible member comprising a distal end;an expandable framework, configured to engage the obstruction, expandable from a collapsed delivery configuration to an expanded configuration, the expandable framework comprising a proximal portion affixed to the distal end of the elongate flexible member and a tubular portion extending distally from the proximal portion, the tubular portion comprising an elongated tubular shape when the expandable framework is in the expanded configuration, and the proximal portion tapering proximally from the tubular portion to the distal end of the flexible member when the expandable framework is in the expanded configuration; anda fluid-impermeable membrane affixed to the proximal portion of the expandable framework when the expandable framework is in the expanded configuration, the fluid-impermeable membrane further affixed to the tubular portion and extending into the lumen of the outer catheter when the expandable framework is in the expanded configuration, the fluid-impermeable membrane terminating distal of a proximal end of the expandable framework, and the fluid-impermeable membrane comprising a funnel shape around the proximal portion of the expandable framework when the expandable framework is in the expanded configuration,wherein the expandable framework further comprises a closed distal end portion extending distally from the tubular portion and radially inward to a central axis of the tubular portion.
  • 8. The system of claim 7, further comprising: a microcatheter sized to traverse the lumen of the outer catheter,wherein the expandable framework is sized to traverse a lumen of the microcatheter when the expandable framework is in the collapsed delivery configuration.
  • 9. The system of claim 7, wherein the tubular portion is expandable to circumferentially appose a lumen of the blood vessel when the expandable framework is in the expanded configuration.
  • 10. The system of claim 7, wherein, when the expandable framework is in the expanded configuration, the fluid-impermeable membrane comprises a first outer circumference approximately equal to an inner circumference of the lumen of the outer catheter, and a second outer circumference approximately equal to an inner circumference of the blood vessel.
  • 11. The system of claim 7, wherein when the expandable framework is in the expanded configuration, at least a portion of the proximal portion of the expandable framework is positioned within the lumen of the outer catheter, providing an outward force to the lumen of the outer catheter, andwherein the force is effective to create a fluid-impermeable seal between the fluid-impermeable membrane and the lumen of the outer catheter.
US Referenced Citations (821)
Number Name Date Kind
4243040 Beecher Jan 1981 A
4324262 Hall Apr 1982 A
4351342 Wiita et al. Sep 1982 A
4575371 Nordqvist et al. Mar 1986 A
4592356 Gutierrez Jun 1986 A
4719924 Crittenden et al. Jan 1988 A
4738666 Fuqua Apr 1988 A
4767404 Renton Aug 1988 A
4793348 Palmaz Dec 1988 A
4873978 Ginsburg Oct 1989 A
5011488 Ginsburg Apr 1991 A
5092839 Kipperman Mar 1992 A
5102415 Guenther et al. Apr 1992 A
5122136 Guglielmi et al. Jun 1992 A
5123840 Nates Jun 1992 A
5171233 Amplatz Dec 1992 A
5234437 Sepetka Aug 1993 A
5256144 Kraus et al. Oct 1993 A
5261916 Engelson Nov 1993 A
5372124 Takayama et al. Dec 1994 A
5385562 Adams Jan 1995 A
5387219 Rappe Feb 1995 A
5387226 Miraki Feb 1995 A
5396902 Brennen et al. Mar 1995 A
5449372 Schmaltz Sep 1995 A
5520651 Sutcu May 1996 A
5538512 Zenzon et al. Jul 1996 A
5549626 Miller et al. Aug 1996 A
5558652 Henke Sep 1996 A
5601600 Ton Feb 1997 A
5609627 Goicoechea et al. Mar 1997 A
5624461 Mariant Apr 1997 A
5639277 Mariant Jun 1997 A
5645558 Horton Jul 1997 A
5658296 Bates Aug 1997 A
5662671 Barbut Sep 1997 A
5695519 Summer et al. Dec 1997 A
5709704 Nott et al. Jan 1998 A
5713853 Clark Feb 1998 A
5728078 Powers, Jr. Mar 1998 A
5769871 Mers Kelly Jun 1998 A
5779716 Cano Jul 1998 A
5810874 Lefebvre Sep 1998 A
5814064 Danniel et al. Sep 1998 A
5827304 Hart Oct 1998 A
5846251 Hart Dec 1998 A
5855598 Pinchuk Jan 1999 A
5893869 Barnhart et al. Apr 1999 A
5895398 Wensel Apr 1999 A
5897567 Ressemann Apr 1999 A
5904698 Thomas et al. May 1999 A
5911725 Boury Jun 1999 A
5935139 Bates Aug 1999 A
5938645 Gordon Aug 1999 A
5947995 Samuels Sep 1999 A
5968057 Taheri Oct 1999 A
5971938 Hart et al. Oct 1999 A
5997939 Moechnig et al. Dec 1999 A
6022343 Johnson et al. Feb 2000 A
6063113 Kavteladze May 2000 A
6066149 Samson et al. May 2000 A
6066158 Engelson May 2000 A
6093196 Okada Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096053 Bates Aug 2000 A
6099534 Bates Aug 2000 A
6102932 Kurz Aug 2000 A
6106548 Roubin et al. Aug 2000 A
6129739 Khosravi Oct 2000 A
6142957 Diamond et al. Nov 2000 A
6146396 Kónya et al. Nov 2000 A
6146404 Kim Nov 2000 A
6165194 Denardo Dec 2000 A
6165199 Barbut Dec 2000 A
6168604 Cano Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6174318 Bates et al. Jan 2001 B1
6179861 Khosravi Jan 2001 B1
6203561 Ramee Mar 2001 B1
6214026 Epak Apr 2001 B1
6221006 Dubrul Apr 2001 B1
6238412 Dubrul May 2001 B1
6245087 Addis Jun 2001 B1
6251122 Tsukernik Jun 2001 B1
6254571 Hart Jul 2001 B1
6264663 Cano Jul 2001 B1
6306163 Fitz Oct 2001 B1
6309379 Willard Oct 2001 B1
6312407 Zando-Azizi et al. Nov 2001 B1
6312444 Barbut Nov 2001 B1
6315778 Gambale et al. Nov 2001 B1
6325819 Pavcnik et al. Dec 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6336934 Gilson et al. Jan 2002 B1
6348056 Bates Feb 2002 B1
6350271 Kurz et al. Feb 2002 B1
6361545 Macoviak Mar 2002 B1
6371963 Nishtala et al. Apr 2002 B1
6375668 Gifford et al. Apr 2002 B1
6383205 Samson et al. May 2002 B1
6383206 Gillick May 2002 B1
6391037 Greenhalgh May 2002 B1
6402771 Palmer Jun 2002 B1
6409683 Fonseca et al. Jun 2002 B1
6416541 Denardo Jul 2002 B2
6425909 Dieck et al. Jul 2002 B1
6432122 Gilson et al. Aug 2002 B1
6436112 Wensel Aug 2002 B2
6458139 Palmer Oct 2002 B1
6346116 Brooks et al. Nov 2002 B1
6485497 Wensel Nov 2002 B2
6485501 Green Nov 2002 B1
6485502 Don Michael Nov 2002 B2
6511492 Rosenbluth Jan 2003 B1
6517551 Driskill Feb 2003 B1
6520934 Lee et al. Feb 2003 B1
6520951 Carrillo, Jr. Feb 2003 B1
6530935 Wensel Mar 2003 B2
6530939 Hopkins Mar 2003 B1
6540768 Diaz et al. Apr 2003 B1
6544279 Hopkins Apr 2003 B1
6551341 Boylan et al. Apr 2003 B2
6551342 Shen et al. Apr 2003 B1
6575997 Palmer et al. Jun 2003 B1
6582448 Boyle Jun 2003 B1
6585756 Strecker Jul 2003 B1
6589265 Palmer et al. Jul 2003 B1
6592607 Palmer et al. Jul 2003 B1
6592616 Stack Jul 2003 B1
6602271 Adams Aug 2003 B2
6602272 Boylan et al. Aug 2003 B2
6605102 Mazzocchi et al. Aug 2003 B1
6610077 Hancock et al. Aug 2003 B1
6616679 Khosravi Sep 2003 B1
6632241 Hanoock et al. Oct 2003 B1
6638245 Miller Oct 2003 B2
6638293 Makower et al. Oct 2003 B1
6641590 Palmer et al. Nov 2003 B1
6652555 VanTassel et al. Nov 2003 B1
6656218 Denardo et al. Dec 2003 B1
6660021 Palmer et al. Dec 2003 B1
6663650 Sepetka Dec 2003 B2
6673089 Yassour et al. Jan 2004 B1
6685722 Rosenbluth Feb 2004 B1
6692504 Kurz et al. Feb 2004 B2
6692508 Wensel Feb 2004 B2
6692509 Wensel Feb 2004 B2
6702782 Miller Mar 2004 B2
6712834 Yassour et al. Mar 2004 B2
6726701 Gilson et al. Apr 2004 B2
6730104 Sepetka May 2004 B1
6726703 Broome et al. Aug 2004 B2
6824545 Sepetka Nov 2004 B2
6855155 Denardo et al. Feb 2005 B2
6878163 Denardo et al. Apr 2005 B2
6890340 Duane May 2005 B2
6913612 Palmer Jul 2005 B2
6913618 Denardo et al. Jul 2005 B2
6953472 Palmer et al. Oct 2005 B2
6989019 Mazzocchi Jan 2006 B2
6989021 Bosma et al. Jan 2006 B2
6994718 Groothuis et al. Feb 2006 B2
6997939 Linder Feb 2006 B2
7004954 Voss et al. Feb 2006 B1
7004955 Shen Feb 2006 B2
7004956 Palmer Feb 2006 B2
7008434 Kurz et al. Mar 2006 B2
7033376 Tsukernik Apr 2006 B2
7041116 Goto May 2006 B2
7048758 Boyle May 2006 B2
7058456 Pierce Jun 2006 B2
7063707 Bose Jun 2006 B2
7153320 Euteneuer et al. Dec 2006 B2
7175655 Malaei Feb 2007 B1
7179273 Palmer et al. Feb 2007 B1
7220269 Ansel May 2007 B1
7220271 Clubb May 2007 B2
7226464 Gamer et al. Jun 2007 B2
7229472 DePalma et al. Jun 2007 B2
7232462 Schaeffer Jun 2007 B2
7288112 Denardo et al. Oct 2007 B2
7306618 Demond Dec 2007 B2
7316692 Huffmaster Jan 2008 B2
7323001 Cubb Jan 2008 B2
7331976 McGuckin, Jr. et al. Feb 2008 B2
7344550 Carrison et al. Mar 2008 B2
7399308 Borillo et al. Jul 2008 B2
7410491 Hopkins Aug 2008 B2
7452496 Brady et al. Nov 2008 B2
7491215 Vale et al. Feb 2009 B2
7491216 Brady Feb 2009 B2
7510565 Gilson et al. Mar 2009 B2
7534252 Sepetka May 2009 B2
7556636 Mazzocchi Jul 2009 B2
7582111 Krolik et al. Sep 2009 B2
7594926 Inder Sep 2009 B2
7604649 McGuckin et al. Oct 2009 B2
7618434 Santra et al. Nov 2009 B2
7662165 Gilson et al. Feb 2010 B2
7670356 Mazzocchi Mar 2010 B2
7691121 Rosenbluth Apr 2010 B2
7691124 Balgobin Apr 2010 B2
7708770 Linder May 2010 B2
7736385 Agnew Jun 2010 B2
7766934 Pal Aug 2010 B2
7771452 Pal Aug 2010 B2
7780694 Palmer Aug 2010 B2
7780696 Daniel et al. Aug 2010 B2
7819893 Brady et al. Oct 2010 B2
7828815 Mazzocchi Nov 2010 B2
7846176 Mazzocchi Nov 2010 B2
7846175 Bonnette et al. Dec 2010 B2
7850708 Pal Dec 2010 B2
7887560 Kusleika Feb 2011 B2
7901426 Gilson et al. Mar 2011 B2
7914549 Morsi Mar 2011 B2
7922732 Mazzocchi Apr 2011 B2
7927349 Brady et al. Apr 2011 B2
7927784 Simpson Apr 2011 B2
7931659 Bose et al. Apr 2011 B2
7998165 Huffmaster Aug 2011 B2
8002822 Glocker et al. Aug 2011 B2
8021379 Thompson et al. Sep 2011 B2
8021380 Thompson et al. Sep 2011 B2
8043326 Hancock et al. Oct 2011 B2
8048151 O'Brien et al. Nov 2011 B2
8052640 Fiorella et al. Nov 2011 B2
8057497 Raju et al. Nov 2011 B1
8066757 Ferrera et al. Nov 2011 B2
8070791 Ferrera et al. Dec 2011 B2
8088140 Ferrera et al. Jan 2012 B2
8100935 Rosenbluth et al. Jan 2012 B2
8109941 Richardson Feb 2012 B2
8118829 Carrison et al. Feb 2012 B2
8123769 Osborne Feb 2012 B2
8137377 Palmer Mar 2012 B2
8142422 Makower et al. Mar 2012 B2
8142442 Palmer et al. Mar 2012 B2
8182508 Magnuson et al. May 2012 B2
8187298 Pal May 2012 B2
8246641 Osborne et al. Aug 2012 B2
8246672 Osborne Aug 2012 B2
8252017 Paul, Jr. et al. Aug 2012 B2
8252018 Valaie Aug 2012 B2
8357178 Grandfield et al. Jan 2013 B2
8357179 Grandfield et al. Jan 2013 B2
8357893 Xu et al. Jan 2013 B2
8361095 Osborne Jan 2013 B2
8366663 Fiorella et al. Feb 2013 B2
8372133 Douk et al. Feb 2013 B2
8382742 Hermann et al. Feb 2013 B2
8409215 Sepetka et al. Apr 2013 B2
8419748 Valaie Apr 2013 B2
8460312 Bose et al. Jun 2013 B2
8460313 Huffmaster Jun 2013 B2
8486104 Samson et al. Jul 2013 B2
8529596 Grandfield et al. Sep 2013 B2
8574262 Ferrera et al. Nov 2013 B2
8579915 French et al. Nov 2013 B2
8585643 Vo et al. Nov 2013 B2
8585713 Ferrera et al. Nov 2013 B2
8608761 Osbourne et al. Dec 2013 B2
8679142 Slee et al. Mar 2014 B2
8696622 Fiorella et al. Apr 2014 B2
8702652 Fiorella et al. Apr 2014 B2
8702724 Olsen et al. Apr 2014 B2
8784434 Rosenbluth et al. Jul 2014 B2
8784441 Rosenbluth et al. Jul 2014 B2
8795305 Grandfield et al. Aug 2014 B2
8795317 Grandfield et al. Aug 2014 B2
8795345 Grandfield et al. Aug 2014 B2
8814892 Galdonik et al. Aug 2014 B2
8814925 Hilaire et al. Aug 2014 B2
8900265 Ulm, III Dec 2014 B1
8939991 Krolick et al. Jan 2015 B2
8945143 Ferrera et al. Feb 2015 B2
8945172 Ferrera et al. Feb 2015 B2
8968330 Rosenbluth et al. Mar 2015 B2
9039749 Shrivastava et al. May 2015 B2
9072537 Grandfield et al. Jul 2015 B2
9113936 Palmer et al. Aug 2015 B2
9119656 Bose et al. Sep 2015 B2
9138307 Valaie Sep 2015 B2
9149609 Ansel et al. Oct 2015 B2
9155552 Ulm, III Oct 2015 B2
9161766 Slee et al. Oct 2015 B2
9173668 Ulm, III Nov 2015 B2
9186487 Dubrul et al. Nov 2015 B2
9198687 Fulkerson et al. Dec 2015 B2
9204887 Cully et al. Dec 2015 B2
9221132 Bowman Dec 2015 B2
9232992 Heidner Jan 2016 B2
9532792 Galdonik et al. Jan 2017 B2
9532873 Kelley Jan 2017 B2
9533344 Monetti et al. Jan 2017 B2
9539011 Chen et al. Jan 2017 B2
9539022 Bowman Jan 2017 B2
9539122 Burke et al. Jan 2017 B2
9539382 Nelson Jan 2017 B2
9549830 Bruszewski et al. Jan 2017 B2
9554805 Tompkins et al. Jan 2017 B2
9561125 Bowman et al. Feb 2017 B2
9572982 Bumes et al. Feb 2017 B2
9579484 Barnell Feb 2017 B2
9585642 Dinsmoor et al. Mar 2017 B2
9615832 Bose et al. Apr 2017 B2
9615951 Bennett et al. Apr 2017 B2
9622753 Cox Apr 2017 B2
9636115 Henry et al. May 2017 B2
9636439 Chu et al. May 2017 B2
9642635 Vale et al. May 2017 B2
9642675 Werneth et al. May 2017 B2
9655633 Leynov et al. May 2017 B2
9655645 Staunton May 2017 B2
9655989 Cruise et al. May 2017 B2
9662129 Galdonik et al. May 2017 B2
9662238 Dwork et al. May 2017 B2
9662425 Lilja et al. May 2017 B2
9668898 Wong Jun 2017 B2
9675477 Thompson Jun 2017 B2
9675782 Connolly Jun 2017 B2
9676022 Ensign et al. Jun 2017 B2
9692557 Murphy Jun 2017 B2
9693852 Lam et al. Jul 2017 B2
9700262 Janik et al. Jul 2017 B2
9700399 Acosta-Acevedo Jul 2017 B2
9717421 Griswold et al. Aug 2017 B2
9717500 Tieu et al. Aug 2017 B2
9717502 Teoh et al. Aug 2017 B2
9724103 Cruise et al. Aug 2017 B2
9724526 Strother et al. Aug 2017 B2
9750565 Bloom et al. Sep 2017 B2
9757260 Greenan Sep 2017 B2
9764111 Gulachenski Sep 2017 B2
9770251 Bowman et al. Sep 2017 B2
9770577 Li et al. Sep 2017 B2
9775621 Tompkins et al. Oct 2017 B2
9775706 Peterson et al. Oct 2017 B2
9775732 Khenansho Oct 2017 B2
9788800 Mayoras, Jr. Oct 2017 B2
9795391 Saatchi et al. Oct 2017 B2
9801980 Karino et al. Oct 2017 B2
9808599 Bowman et al. Nov 2017 B2
9833252 Sepetka et al. Dec 2017 B2
9833604 Lam et al. Dec 2017 B2
9833625 Waldhauser et al. Dec 2017 B2
10028759 Wallace et al. Jul 2018 B2
10149692 Turjman et al. Dec 2018 B2
10265086 Vale Apr 2019 B2
10716915 Ogle et al. Jul 2020 B2
10610668 Burkholz et al. Aug 2020 B2
10835271 Ma Nov 2020 B2
11076879 Yee et al. Aug 2021 B2
20010001315 Bates May 2001 A1
20010011182 Dubrul et al. Aug 2001 A1
20010016755 Addis Aug 2001 A1
20010041899 Foster Nov 2001 A1
20010044598 Parodi Nov 2001 A1
20010044634 Don Michael et al. Nov 2001 A1
20010051810 Dubrul Dec 2001 A1
20020002383 Sepetka et al. Jan 2002 A1
20020016609 Wensel Feb 2002 A1
20020022859 Hogendijk Feb 2002 A1
20020026211 Khosravi Feb 2002 A1
20020049468 Streeter Apr 2002 A1
20020052620 Barvut May 2002 A1
20020068954 Foster Jun 2002 A1
20020072764 Sepetka Jun 2002 A1
20020082558 Samson Jun 2002 A1
20020091407 Zadno-Azizi et al. Jul 2002 A1
20020095171 Belef Jul 2002 A1
20020123765 Sepetka Sep 2002 A1
20020143362 Macoviak et al. Oct 2002 A1
20020156455 Barbut Oct 2002 A1
20020161393 Demond Oct 2002 A1
20020165576 Boyle et al. Nov 2002 A1
20020173819 Leeflang et al. Nov 2002 A1
20020177800 Bagaoisan et al. Nov 2002 A1
20020188276 Evans Dec 2002 A1
20030004536 Boylan et al. Jan 2003 A1
20030004538 Secrest Jan 2003 A1
20030004542 Wensel Jan 2003 A1
20030009146 Muni Jan 2003 A1
20030009191 Wensel Jan 2003 A1
20030023204 Vo et al. Jan 2003 A1
20030040769 Kelley et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030050663 Khachin Mar 2003 A1
20030105484 Boyle et al. Jun 2003 A1
20030125798 Matrin Jul 2003 A1
20030130682 Broome et al. Jul 2003 A1
20030144687 Brady et al. Jul 2003 A1
20030144689 Brady et al. Jul 2003 A1
20030153940 Nohilly et al. Aug 2003 A1
20030153943 Michael et al. Aug 2003 A1
20030153944 Phung Aug 2003 A1
20030163064 Vrba Aug 2003 A1
20030163158 Wlite Aug 2003 A1
20030171769 Barbu Sep 2003 A1
20030176884 Berrada et al. Sep 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030195537 Dubrul Oct 2003 A1
20030195554 Shen Oct 2003 A1
20030199917 Knudson Oct 2003 A1
20030204202 Palmer Oct 2003 A1
20030212430 Bose Nov 2003 A1
20030216611 Q. Vu Nov 2003 A1
20030236533 Wilson Dec 2003 A1
20040010280 Adams et al. Jan 2004 A1
20040010282 Kusleika Jan 2004 A1
20040014002 Lundgren Jan 2004 A1
20040068288 Palmer et al. Apr 2004 A1
20040073243 Sepetka Apr 2004 A1
20040079429 Miller Apr 2004 A1
20040082962 Demarais et al. Apr 2004 A1
20040093065 Yachia et al. May 2004 A1
20040133231 Maitland Jul 2004 A1
20040138692 Phung Jul 2004 A1
20040153049 Tewitt et al. Aug 2004 A1
20040153118 Clubb Aug 2004 A1
20040193107 Pierpont et al. Sep 2004 A1
20040199202 Dubrul et al. Oct 2004 A1
20040260333 Dubrul et al. Dec 2004 A1
20050015047 Shah Jan 2005 A1
20050020974 Noriega Jan 2005 A1
20050033348 Sepetka Feb 2005 A1
20050038447 Huffmaster Feb 2005 A1
20050038468 Panetta et al. Feb 2005 A1
20050049619 Sepetka Mar 2005 A1
20050049669 Jones Mar 2005 A1
20050049670 Jones et al. Mar 2005 A1
20050055033 Eslie et al. Mar 2005 A1
20050055047 Greenhalgh Mar 2005 A1
20050059993 Ramzipoor et al. Mar 2005 A1
20050059995 Sepetka Mar 2005 A1
20050085849 Sepetka Apr 2005 A1
20050090857 Kusleika et al. Apr 2005 A1
20050119524 Sckine et al. Jun 2005 A1
20050119668 Teague et al. Jun 2005 A1
20050125024 Sepetka Jun 2005 A1
20050131449 Salahieh et al. Jun 2005 A1
20050149111 Kanazawa et al. Jul 2005 A1
20050171566 Kanamaru Aug 2005 A1
20050187570 Nguyen et al. Aug 2005 A1
20050267491 Kellett et al. Aug 2005 A1
20050216030 Sepetka Sep 2005 A1
20050216050 Sepetka Sep 2005 A1
20050288686 Sepetka Sep 2005 A1
20050228417 Teitelbaum et al. Oct 2005 A1
20060009785 Maitland et al. Jan 2006 A1
20060009799 Kleshinski et al. Jan 2006 A1
20060010636 Vacher Jan 2006 A1
20060030933 DeLeggge et al. Feb 2006 A1
20060036271 Schomer et al. Feb 2006 A1
20060058836 Bose Mar 2006 A1
20060058837 Bose Mar 2006 A1
20060058838 Bose Mar 2006 A1
20060064151 Guterman et al. Mar 2006 A1
20060149313 Arguello et al. Jul 2006 A1
20060155305 Freudenthal Jul 2006 A1
20060155322 Sater et al. Jul 2006 A1
20060161187 Levine et al. Jul 2006 A1
20060195137 Sepetka Aug 2006 A1
20060224177 Finitsis Oct 2006 A1
20060224179 Kucharczyk Oct 2006 A1
20060229638 Abrams et al. Oct 2006 A1
20060282111 Morsi Dec 2006 A1
20060287701 Pal Dec 2006 A1
20070088383 Pal et al. Apr 2007 A1
20070142858 Bates Jun 2007 A1
20070149996 Coughlin Jun 2007 A1
20070156170 Hancock Jul 2007 A1
20070165170 Fukuda Jul 2007 A1
20070179513 Deutsch Aug 2007 A1
20070191866 Palmer et al. Aug 2007 A1
20070198028 Miloslavski Aug 2007 A1
20070198051 Clubb et al. Aug 2007 A1
20070198075 Levy Aug 2007 A1
20070208367 Fiorella Sep 2007 A1
20070208371 French Sep 2007 A1
20070213765 Adams Sep 2007 A1
20070225749 Martin Sep 2007 A1
20070239182 Glines et al. Oct 2007 A1
20070239254 Chia et al. Oct 2007 A1
20070244505 Gilson et al. Oct 2007 A1
20070270902 Slazas et al. Nov 2007 A1
20070288038 Bimbo Dec 2007 A1
20070293887 Okushi et al. Dec 2007 A1
20080045881 Teitelbaum et al. Feb 2008 A1
20080082107 Miller et al. Apr 2008 A1
20080086190 Ta Apr 2008 A1
20080091223 Pokorney Apr 2008 A1
20080097398 Mitelberg Apr 2008 A1
20080109031 Sepetka May 2008 A1
20080109032 Sepetka May 2008 A1
20080119886 Greenhalgh et al. May 2008 A1
20080177296 Sepetka Jul 2008 A1
20080183197 Sepetka Jul 2008 A1
20080183198 Sepetka Jul 2008 A1
20080183205 Sepetka Jul 2008 A1
20080188876 Sepetka Aug 2008 A1
20080188885 Sepetka Aug 2008 A1
20080188928 Salahieh Aug 2008 A1
20080200946 Braun Aug 2008 A1
20080215077 Sepetka Sep 2008 A1
20080221600 Dieck et al. Sep 2008 A1
20080228209 DeMello et al. Sep 2008 A1
20080234706 Sepetka Sep 2008 A1
20080243170 Jenson Oct 2008 A1
20080255596 Jenson Oct 2008 A1
20080262528 Martin Oct 2008 A1
20080262532 Martin Oct 2008 A1
20080269774 Garcia et al. Oct 2008 A1
20080275488 Fleming Nov 2008 A1
20080275493 Farmiga Nov 2008 A1
20080281350 Sepetka Nov 2008 A1
20080312681 Ansel Dec 2008 A1
20090024157 Anukhin Jan 2009 A1
20090054918 Henson Feb 2009 A1
20090069828 Martin Mar 2009 A1
20090076539 Valaie Mar 2009 A1
20090105722 Fulkerson Apr 2009 A1
20090105737 Fulkerson Apr 2009 A1
20090131908 Mckay May 2009 A1
20090163846 Aklog et al. May 2009 A1
20090177206 Lozier et al. Jul 2009 A1
20090182336 Brenzel et al. Jul 2009 A1
20090221967 Thommen et al. Sep 2009 A1
20090270815 Stamp et al. Oct 2009 A1
20090281610 Parker Nov 2009 A1
20090292297 Ferrere Nov 2009 A1
20090292307 Razack Nov 2009 A1
20090299374 Tilson et al. Dec 2009 A1
20090299393 Martin Dec 2009 A1
20090306702 Miloslavski Dec 2009 A1
20100004607 Wilson et al. Jan 2010 A1
20100016957 Jager et al. Jan 2010 A1
20100030186 Stivland Feb 2010 A1
20100030256 Dubrul et al. Feb 2010 A1
20100036312 Krolik et al. Feb 2010 A1
20100087908 Hilaire Apr 2010 A1
20100114017 Lenker May 2010 A1
20100125326 Kalstad May 2010 A1
20100125327 Agnew May 2010 A1
20100191272 Keating Jul 2010 A1
20100211094 Sargent, Jr. Aug 2010 A1
20100249815 Jantzen et al. Sep 2010 A1
20100268264 Bonnett et al. Oct 2010 A1
20100268265 Krolik Oct 2010 A1
20100292726 Olsen et al. Nov 2010 A1
20100305566 Rosenblatt et al. Dec 2010 A1
20100305604 Pah Dec 2010 A1
20100318178 Rapaport et al. Dec 2010 A1
20100324649 Mattsson Dec 2010 A1
20100331949 Habib Dec 2010 A1
20110009875 Grandfield et al. Jan 2011 A1
20110009940 Grandfield et al. Jan 2011 A1
20110009942 Gregorich Jan 2011 A1
20110022149 Cox et al. Jan 2011 A1
20110054514 Arcand Mar 2011 A1
20110054516 Keegan Mar 2011 A1
20110060359 Hannes Mar 2011 A1
20110071432 Carrillo, Jr. et al. Mar 2011 A1
20110077620 deBeer Mar 2011 A1
20110098683 Wiita et al. Apr 2011 A1
20110054504 Wolf et al. May 2011 A1
20110125181 Brady et al. May 2011 A1
20110130756 Everson, Jr. et al. Jun 2011 A1
20110152920 Eckhouse et al. Jun 2011 A1
20110160763 Ferrera et al. Jun 2011 A1
20110166586 Sepetka et al. Jul 2011 A1
20110196414 Porter et al. Aug 2011 A1
20110202088 Eckhouse et al. Aug 2011 A1
20110213290 Chin et al. Sep 2011 A1
20110213297 Aklog et al. Sep 2011 A1
20110213393 Aklog et al. Sep 2011 A1
20110213403 Aboytes Sep 2011 A1
20110218564 Drasler et al. Sep 2011 A1
20110224707 Miloslavaski et al. Sep 2011 A1
20110264132 Strauss et al. Oct 2011 A1
20110276120 Gilson et al. Nov 2011 A1
20110319917 Ferrera et al. Dec 2011 A1
20120041449 Eckhouse et al. Feb 2012 A1
20120041474 Eckhouse et al. Feb 2012 A1
20120059356 diPama et al. Mar 2012 A1
20120089216 Rapaport et al. Apr 2012 A1
20120101510 Lenker et al. Apr 2012 A1
20120116351 Chomas et al. May 2012 A1
20120116440 Leynov et al. May 2012 A1
20120143237 Cam et al. Jun 2012 A1
20120143239 Aklog et al. Jun 2012 A1
20120150147 Leynov et al. Jun 2012 A1
20120165858 Eckhouse et al. Jun 2012 A1
20120165859 Eckhouse et al. Jun 2012 A1
20120215250 Grandfield et al. Aug 2012 A1
20120277788 Cattaneo Nov 2012 A1
20120283768 Cox et al. Nov 2012 A1
20120296362 Cam et al. Nov 2012 A1
20120316600 Ferrera et al. Dec 2012 A1
20130006284 Aggerholm et al. Jan 2013 A1
20130030461 Marks et al. Jan 2013 A1
20130046330 McIntosh et al. Feb 2013 A1
20130046333 Jones et al. Feb 2013 A1
20130046334 Jones et al. Feb 2013 A1
20130116774 Strauss et al. May 2013 A1
20130131614 Hassan et al. May 2013 A1
20130144326 Brady et al. Jun 2013 A1
20130144328 Weber et al. Jun 2013 A1
20130158592 Porter Jun 2013 A1
20130184703 Shireman et al. Jul 2013 A1
20130184739 Brady et al. Jul 2013 A1
20130197567 Brady et al. Aug 2013 A1
20130226146 Tekulve Aug 2013 A1
20130268050 Wilson et al. Oct 2013 A1
20130281788 Garrison Oct 2013 A1
20130289697 Baker et al. Oct 2013 A1
20130325055 Eckhouse et al. Dec 2013 A1
20130325056 Eckhouse et al. Dec 2013 A1
20130345739 Brady et al. Dec 2013 A1
20140012281 Wang et al. Jan 2014 A1
20140046359 Bowman et al. Feb 2014 A1
20140052097 Petersen et al. Feb 2014 A1
20140081243 Zhou et al. Mar 2014 A1
20140121672 Folk May 2014 A1
20140128905 Molaei May 2014 A1
20140135812 Divino et al. May 2014 A1
20140180377 Bose et al. Jun 2014 A1
20140188127 Dubrul et al. Jul 2014 A1
20140194919 Losordo et al. Jul 2014 A1
20140200607 Sepetka et al. Jul 2014 A1
20140200608 Brady et al. Jul 2014 A1
20140236220 Inoue Aug 2014 A1
20140257018 Farnan Sep 2014 A1
20140257362 Eldenschink Sep 2014 A1
20140276922 McLain et al. Sep 2014 A1
20140277003 Hendrick Sep 2014 A1
20140277053 Wang et al. Sep 2014 A1
20140277079 Vale et al. Sep 2014 A1
20140309657 Ben-Ami Oct 2014 A1
20140309673 Dacuycuy et al. Oct 2014 A1
20140330302 Tekulve et al. Nov 2014 A1
20140343585 Ferrera et al. Nov 2014 A1
20140364896 Consigny Dec 2014 A1
20140371769 Vale et al. Dec 2014 A1
20140371777 Rudakov et al. Dec 2014 A1
20140371779 Vale et al. Dec 2014 A1
20140371780 Vale et al. Dec 2014 A1
20140379023 Brady et al. Dec 2014 A1
20150018859 Quick et al. Jan 2015 A1
20150018860 Quick et al. Jan 2015 A1
20150080937 Davidson Mar 2015 A1
20150081003 Wainwright et al. Mar 2015 A1
20150112376 Molaei et al. Apr 2015 A1
20150133990 Davidson May 2015 A1
20150142043 Furey May 2015 A1
20150164523 Brady et al. Jun 2015 A1
20150173782 Garrison et al. Jun 2015 A1
20150173783 Tah et al. Jun 2015 A1
20150238314 Börtlein et al. Aug 2015 A1
20150250497 Marks et al. Sep 2015 A1
20150257775 Gilvarry et al. Sep 2015 A1
20150258270 Kunis Sep 2015 A1
20150290437 Rudakov et al. Oct 2015 A1
20150297252 Miloslavski et al. Oct 2015 A1
20150306311 Pinchuk et al. Oct 2015 A1
20150313617 Grandfield et al. Nov 2015 A1
20150320431 Ulm, III Nov 2015 A1
20150351770 Fulton, III Dec 2015 A1
20150352325 Quick Dec 2015 A1
20150359547 Vale et al. Dec 2015 A1
20150374391 Quick et al. Dec 2015 A1
20150374393 Brady et al. Dec 2015 A1
20150374479 Vale Dec 2015 A1
20160015402 Brady et al. Jan 2016 A1
20160022296 Brady et al. Jan 2016 A1
20160066921 Brady et al. Mar 2016 A1
20160074067 Furnish et al. Mar 2016 A1
20160106448 Brady et al. Apr 2016 A1
20160106449 Brady et al. Apr 2016 A1
20160113663 Brady et al. Apr 2016 A1
20160113664 Brady et al. Apr 2016 A1
20160113665 Brady et al. Apr 2016 A1
20160120558 Brady et al. May 2016 A1
20160121080 Cottone May 2016 A1
20160135829 Holochwost et al. May 2016 A1
20160143653 Vale et al. May 2016 A1
20160151079 Aklog et al. Jun 2016 A1
20160192953 Brady et al. Jul 2016 A1
20160192954 Brady et al. Jul 2016 A1
20160192955 Brady et al. Jul 2016 A1
20160192956 Brady et al. Jul 2016 A1
20160228134 Martin et al. Aug 2016 A1
20160256180 Vale et al. Sep 2016 A1
20160262880 Li et al. Sep 2016 A1
20160317168 Brady et al. Nov 2016 A1
20160346002 Avneri et al. Dec 2016 A1
20170007264 Cruise et al. Jan 2017 A1
20170007265 Guo et al. Jan 2017 A1
20170020670 Murray et al. Jan 2017 A1
20170020700 Bienvenu et al. Jan 2017 A1
20170027640 Kunis et al. Feb 2017 A1
20170027692 Bonhoeffer et al. Feb 2017 A1
20170027725 Argentine Feb 2017 A1
20170035436 Morita Feb 2017 A1
20170035567 Duffy Feb 2017 A1
20170042548 Lam Feb 2017 A1
20170049596 Schabert Feb 2017 A1
20170065401 Fearnot et al. Mar 2017 A1
20170071614 Vale et al. Mar 2017 A1
20170071737 Kelley Mar 2017 A1
20170072452 Monetti et al. Mar 2017 A1
20170079671 Morero et al. Mar 2017 A1
20170079680 Bowman Mar 2017 A1
20170079766 Wang et al. Mar 2017 A1
20170079767 Leon-Yip Mar 2017 A1
20170079812 Lam et al. Mar 2017 A1
20170079817 Sepetka et al. Mar 2017 A1
20170079819 Pung et al. Mar 2017 A1
20170079820 Lam et al. Mar 2017 A1
20170086851 Wallace et al. Mar 2017 A1
20170086862 Vale et al. Mar 2017 A1
20170086863 Brady et al. Mar 2017 A1
20170086864 Greenhalgh et al. Mar 2017 A1
20170086996 Peterson et al. Mar 2017 A1
20170239447 Greenhalgh et al. Mar 2017 A1
20170095138 Nakade et al. Apr 2017 A1
20170095259 Tompkins et al. Apr 2017 A1
20170100126 Bowman et al. Apr 2017 A1
20170100141 Morero et al. Apr 2017 A1
20170100143 Granfield Apr 2017 A1
20170100183 Iaizzo et al. Apr 2017 A1
20170105743 Vale Apr 2017 A1
20170112515 Brady et al. Apr 2017 A1
20170113023 Steingisser et al. Apr 2017 A1
20170147765 Mehta May 2017 A1
20170151032 Loisel Jun 2017 A1
20170165062 Rothstein Jun 2017 A1
20170165065 Rothstein et al. Jun 2017 A1
20170165454 Tuohy et al. Jun 2017 A1
20170172554 Bortlein et al. Jun 2017 A1
20170172581 Bose et al. Jun 2017 A1
20170172766 Vong et al. Jun 2017 A1
20170172772 Khenansho Jun 2017 A1
20170189033 Sepetka et al. Jul 2017 A1
20170189035 Porter Jul 2017 A1
20170215902 Leynov et al. Aug 2017 A1
20170216484 Cruise et al. Aug 2017 A1
20170224350 Shimizu et al. Aug 2017 A1
20170224355 Bowman et al. Aug 2017 A1
20170224467 Piccagli et al. Aug 2017 A1
20170224511 Dwork et al. Aug 2017 A1
20170224953 Tran et al. Aug 2017 A1
20170231749 Perkins et al. Aug 2017 A1
20170238953 Yang et al. Aug 2017 A1
20170252043 Fuller et al. Sep 2017 A1
20170252064 Staunton Sep 2017 A1
20170259042 Nguyen et al. Sep 2017 A1
20170265983 Lam et al. Sep 2017 A1
20170281192 Tieu et al. Oct 2017 A1
20170281331 Perkins et al. Oct 2017 A1
20170281344 Costello Oct 2017 A1
20170281909 Northrop et al. Oct 2017 A1
20170281912 Melder et al. Oct 2017 A1
20170290593 Sethna Oct 2017 A1
20170290654 Sethna Oct 2017 A1
20170296324 Argentine Oct 2017 A1
20170296325 Marrocco et al. Oct 2017 A1
20170303939 Greenhalgh et al. Oct 2017 A1
20170303942 Greenhalgh et al. Oct 2017 A1
20170303947 Greenhalgh et al. Oct 2017 A1
20170303948 Wallace et al. Oct 2017 A1
20170304041 Argentine Oct 2017 A1
20170304097 Corwin et al. Oct 2017 A1
20170304595 Nagasrinivasa et al. Oct 2017 A1
20170312109 Le Nov 2017 A1
20170312484 Shipley et al. Nov 2017 A1
20170316561 Helm et al. Nov 2017 A1
20170319826 Bowman et al. Nov 2017 A1
20170333228 Orth et al. Nov 2017 A1
20170333236 Greenan Nov 2017 A1
20170333678 Bowman et al. Nov 2017 A1
20170340383 Bloom et al. Nov 2017 A1
20170348014 Wallace et al. Dec 2017 A1
20170348514 Guyon et al. Dec 2017 A1
20180008407 Maimon et al. Jan 2018 A1
20180042623 Batiste Feb 2018 A1
20180193050 Hawkins et al. Jul 2018 A1
20180193591 Jaroch et al. Jul 2018 A1
20180235743 Farago et al. Aug 2018 A1
20180256177 Cooper et al. Sep 2018 A1
20180303610 Anderson Oct 2018 A1
20190021755 Johnson et al. Jan 2019 A1
20190021759 Krolik et al. Jan 2019 A1
20190029820 Zhou et al. Jan 2019 A1
20190029825 Fitterer et al. Jan 2019 A1
20190046219 Marchand et al. Feb 2019 A1
20190192175 Chida et al. Jun 2019 A1
20190209206 Patel et al. Jul 2019 A1
20190216476 Barry et al. Jul 2019 A1
20190239907 Brady et al. Aug 2019 A1
20190247627 Korkuch et al. Aug 2019 A1
20190255290 Snyder et al. Aug 2019 A1
20190269491 Jalgaonkar et al. Sep 2019 A1
20190274810 Phouasalit et al. Sep 2019 A1
20190298396 Gamba et al. Oct 2019 A1
20190365411 Avneri et al. Dec 2019 A1
20190366049 Hannon et al. Dec 2019 A1
20200038628 Chou et al. Feb 2020 A1
20200214859 Sherburne Jul 2020 A1
20200281611 Kelly et al. Sep 2020 A1
20200353208 Merhi et al. Nov 2020 A1
20200383698 Miao et al. Dec 2020 A1
20210085935 Fahey et al. Mar 2021 A1
20210153883 Casey et al. May 2021 A1
20210153884 Casey et al. May 2021 A1
20210154433 Casey et al. May 2021 A1
20210219821 Appling et al. Jul 2021 A1
20220117614 Salmon et al. Apr 2022 A1
20220125450 Sirhan Apr 2022 A1
20220313426 Gifford, III et al. Oct 2022 A1
20230054898 Gurovich et al. Mar 2023 A1
Foreign Referenced Citations (104)
Number Date Country
1658920 Aug 2005 CN
1972728 May 2007 CN
103071195 May 2013 CN
104507380 Apr 2015 CN
104905873 Sep 2015 CN
105007973 Oct 2015 CN
105307582 Feb 2016 CN
105726163 Jul 2016 CN
106232059 Dec 2016 CN
113040865 Jun 2021 CN
20 2009 001 951 Apr 2010 DE
10 2009 056 450 Jun 2011 DE
10 2010 010 849 Sep 2011 DE
10 2010 014 778 Oct 2011 DE
10 2010 024 085 Dec 2011 DE
10 2011 014 586 Sep 2012 DE
20 2020 107013 Jan 2021 DE
2301450 Mar 2011 EP
2628455 Aug 2013 EP
3302312 Apr 2018 EP
3335647 Jun 2018 EP
3 420 978 Jan 2019 EP
4049704 Aug 2022 EP
2498349 Jul 2013 GB
9-19438 Jan 1997 JP
2006021407 Mar 2006 NO
WO 9304722 Mar 1993 WO
9424926 Nov 1994 WO
9727808 Aug 1997 WO
9738631 Oct 1997 WO
9920335 Apr 1999 WO
9956801 Nov 1999 WO
9960933 Dec 1999 WO
0121077 Mar 2001 WO
0202162 Jan 2002 WO
0211627 Feb 2002 WO
0243616 Jun 2002 WO
02070061 Sep 2002 WO
02094111 Nov 2002 WO
03002006 Jan 2003 WO
03018085 Mar 2003 WO
03030751 Apr 2003 WO
03051448 Jun 2003 WO
2004028571 Apr 2004 WO
2004056275 Jul 2004 WO
2005000130 Jan 2005 WO
2005027779 Mar 2005 WO
WO 2005027751 Mar 2005 WO
2006031410 Mar 2006 WO
2006107641 Oct 2006 WO
2006135823 Dec 2006 WO
2007054307 May 2007 WO
2007068424 Jun 2007 WO
2008034615 Mar 2008 WO
2008051431 May 2008 WO
2008131116 Oct 2008 WO
WO 2009019664 Feb 2009 WO
2009031338 Mar 2009 WO
2009076482 Jun 2009 WO
2009086482 Jul 2009 WO
2009105710 Aug 2009 WO
WO 2009103125 Aug 2009 WO
2010010545 Jan 2010 WO
2010046897 Apr 2010 WO
2010075565 Jul 2010 WO
2010102307 Sep 2010 WO
2010146581 Dec 2010 WO
2011013556 Feb 2011 WO
2011066961 Jun 2011 WO
2011082319 Jul 2011 WO
2011095352 Aug 2011 WO
2011106426 Sep 2011 WO
2011110316 Sep 2011 WO
2012052982 Apr 2012 WO
2012064726 May 2012 WO
2012081020 Jun 2012 WO
2012110619 Aug 2012 WO
2012120490 Sep 2012 WO
2012156924 Nov 2012 WO
2013016435 Jan 2013 WO
2013072777 May 2013 WO
2013105099 Jul 2013 WO
2013109756 Jul 2013 WO
2014081892 May 2014 WO
2014139845 Sep 2014 WO
2014169266 Oct 2014 WO
2014178198 Nov 2014 WO
WO 2014188300 Nov 2014 WO
2015061365 Apr 2015 WO
2015134625 Sep 2015 WO
2015179324 Nov 2015 WO
WO 2015179377 Nov 2015 WO
2015189354 Dec 2015 WO
2016010995 Jan 2016 WO
WO 2017004234 Jan 2017 WO
WO 2017097616 Jun 2017 WO
2018193603 Oct 2018 WO
WO 2018178979 Oct 2018 WO
WO 2019064306 Apr 2019 WO
WO 2019079296 Apr 2019 WO
WO 2020139979 Jul 2020 WO
WO 2021016213 Jan 2021 WO
WO 2021167653 Aug 2021 WO
WO 2022020366 Jan 2022 WO
Non-Patent Literature Citations (3)
Entry
US 6,348,062 B1, 02/2002, Hopkins (withdrawn)
Struffert, T., et al. “Intravenous flat detector CT angiography for non-invasive visualisation of intracranial flow diverter: technical feasibility” Eur Radiol 21:1797-1801 (2011).
Extended European Search Report issued in corresponding EP Application No. 21 16 5800 dated Oct. 27, 2021.
Related Publications (1)
Number Date Country
20210298773 A1 Sep 2021 US